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Abstract
According to World Health Organization estimates, infectious organisms are
responsible for approximately one in four deaths worldwide. Animal models play
an essential role in the development of vaccines and therapeutic agents but large
numbers of animals are required to obtain quantitative microbiological data
by tissue sampling. Biophotonic imaging (BPI) is a highly sensitive, nontoxic
technique based on the detection of visible light, produced by luciferase-catalysed
reactions (bioluminescence) or by excitation of fluorescent molecules, using
sensitive photon detectors. The development of bioluminescent/fluorescent mi-
croorganisms therefore allows the real-time noninvasive detection of microorgan-
isms within intact living animals. Multiple imaging of the same animal throughout
an experiment allows disease progression to be followed with extreme accuracy,
reducing the number of animals required to yield statistically meaningful data. In
the study of infectious disease, the use of BPI is becoming widespread due to the
novel insights it can provide into established models, as well as the impact of the
technique on two of the guiding principles of using animals in research, namely
reduction and refinement. Here, we review the technology of BPI, from the
instrumentation through to the generation of a photonic signal, and illustrate how
the technique is shedding light on infection dynamics in vivo.
Introduction
Light is defined as electromagnetic radiation, particularly of
wavelengths visible to the human eye (approximately
400–700 nm), that exists as tiny ‘packets’ called photons.
Interestingly, light exhibits the properties of both particles
and waves and when it propagates through tissue, undergoes
a range of interactions depending on the structural arrange-
ment and physical properties of the microenvironment.
Such interactions have led to the development of the field
of optical imaging, which encompasses a wide variety of
methods and approaches (Table 1) such as visualizing tissue
anatomy on the microscopic scale using the properties of
light absorption and scattering (Zonios et al., 2001), the
rapidly evolving field of live cell fluorescence microscopy
(Hoppe et al., 2009), intravital microscopy in which the field
of interest is located under a surgically implanted window
(Helmchen & Denk, 2005) and the noninvasive localization
and quantification of a photonic signal three-dimensionally
in whole animals [e.g. by fluorescence molecular tomogra-
phy (FMT); Ntziachristos, 2006].
Within the field of optical imaging, biophotonic imaging
(BPI) is a highly sensitive noninvasive, nontoxic technique
based on the detection of visible light that arises from either
the excitation of a fluorescent protein (FP) or molecule or
from an enzyme-catalysed oxidation reaction (a phenomen-
on known as bioluminescence). Although the light emitted
may be dim, it is detectable externally using sensitive photon
detectors such as those based on cooled, or intensified,
charge coupled device (CCD) cameras, mounted within
light-tight specimen chambers. As light passes through a
range of tissue types (including skin, muscle and bone), it is
possible to observe and quantify the spatial and temporal
distribution of light production from within living animals
(Fig. 1). While researchers typically use commercially avail-
able imaging systems (Table 2), some protocols are available
for those with a more do-it-yourself approach or limited
budget (Zacharakis et al., 2005a, b; Hoffman & Yang, 2006;
Hoffman & Zhao, 2006).
Upon contact with a host organism, pathogenic micro-
organisms utilize a wide variety of strategies to subvert host
cell functions and modulate the immune response.
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Naturally, we wish to understand these strategies and devel-
op interventions to circumvent them. Optical imaging
techniques are at the forefront of such investigations
in vitro. For example, the use of live cell microscopy is
beginning to unravel the localized and transient interactions
between eukaryotic cells and pathogenic microorganisms at
the molecular level (Hoppe et al., 2009). While possessing
some limitations (Wiles et al., 2006a), deliberately induced
infections in well-defined animal models provide much
useful information about disease processes in an approx-
imation of their natural context in vivo. The use of animals is
accompanied by ethical responsibilities and many countries
promote the three Rs: replacement, reduction and refine-
ment. As the name suggests, replacement refers to methods
that avoid or replace the use of animals and include utilizing
computer modelling, established human and animal cell
lines and invertebrate models such as the fruitfly and
nematode. Reduction refers to methods that minimize
animal use and enable researchers to obtain comparable
levels of information from fewer animals or to obtain more
information from the same number of animals, thereby
reducing the future use of animals. Refinement refers to
improvements to scientific procedures and husbandry,
which minimize actual or potential pain, suffering, distress
or lasting harm and/or improve animal welfare.
BPI is a very powerful tool for implementation of two of
the three Rs: refinement and reduction. Using traditional
disease models, infected animals (often 3–10) are sacrificed
at defined time points and tissues are excised for determina-
tion of pathogen numbers and localization. For example, a
six time point experiment would result in the use of 18–60
animals. In contrast, the nondestructive nature of BPI allows
the course of an infection to be monitored simply by
imaging the photonic signal detected from within the same
group of animals, typically six to eight in total. Importantly,
multiple imaging of the same animal throughout an experi-
ment allows disease progression to be followed with extreme
accuracy, while allowing each animal to act as its own
control. Furthermore, when constitutively expressed, biolu-
minescence is related to microbial numbers and can there-
fore be used for quantification of pathogen burden (Francis
et al., 2001; Rocchetta et al., 2001; Wiles et al., 2004;
Rajashekara et al., 2005). This can result in significant
refinements to in vivo models of infectious disease. For
example, in a number of models, death of the animal results
from the rapid and uncontrolled expansion of the infecting
microorganism. With BPI, the photonic signal can be used
to estimate whether an animal will survive or die, allowing
for humane euthanasia perhaps even before the onset of
clinical symptoms. For instance, the appearance of a signal
in the cervical lymph nodes of mice exposed to spores of
luminescent Bacillus anthracis can take from 2 to 4 days, but
it is an unequivocal sign of a failure in the host innate
immune response that leads to dissemination and death
(Loving et al., 2009). In addition, BPI can also result in a
reduction in the levels of stress and/or discomfort experi-
enced by experimental animals by avoiding the need for
invasive sampling procedures routinely used to determine
Table 1. Optical imaging methodologies
Resolution Technique Contrast Depth
Microscopic Epi-microscopy A, Fl 20mm
Confocal microscopy Fl 500mm
Multiphoton microscopy Fl 800mm
Mesoscopic Optical projection tomography A, Fl 15mm
Optical coherence tomography S 2mm
Laser speckle imaging S 1mm
Macroscopic Hyperspectral imaging A, S, Fl o 5mm
Endoscopy A, S, Fl o 5mm
Fluorescence reflectance
imaging (FRI)
A, Fl o 7mm
Diffuse optical tomography (DOT) A, Fl o 20 cm
Fluorescence resonance
imaging (FRI)
A, Fl o 7mm
Fluorescence molecular
tomography (FMT)
Fl o 20 cm
Biophotonic Imaging (BPI) Fl, E o 3 cm
Adapted from Weissleder & Ntziachristos (2003).
A, absorption; Fl, fluorescence; S, scattering; E, emission.
0.5
1.0
1.5
2.0
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24 h
48 h
Photons s
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–2 sr
–1
Fig. 1. Monitoring transmission of the gastrointestinal pathogen Citro-
bacter rodentium through the faecal–oral route using BPI. Mice were
exposed to infectious C. rodentium ICC180 in the cage environment and
transmission and infection dynamics were determined by BPI. Images
were acquired using an IVIS system (Caliper Life Sciences) with an
integration time of 1 min and are displayed as pseudocolour images of
peak bioluminescence, with variations in colour representing light
intensity at a given location. Red represents the most intense light
emission, while blue corresponds to the weakest signal. The colour bar
indicates relative signal intensity (as photons s1 cm2 sr1). The same
four mice were imaged 24 h (top panel) and 48 h (bottom panel) after
introduction into the contaminated cage.
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the bacterial load in specific tissues or fluids such as blood or
the cerebrospinal fluid (Kadurugamuwa et al., 2005c).
Finally, BPI can provide real-time data on the effectiveness
of the inoculation method (Kadurugamuwa et al., 2005c;
Glomski et al., 2007b; Wiles et al., 2007). As a result, errors
in administration can be detected immediately (Fig. 2) and
animals can be eliminated from further study – thus mini-
mizing any potential pain, suffering and distress for the
animal and reducing variation by removing flawed scientific
data.
Factors influencing the sensitivity of BPI
While there are a number of factors that influence the
sensitivity of BPI (Table 3), the main considerations are (1)
the inherent features relating to the propagation of light
through tissue, (2) the inherent background signals within
living animals and (3) the availability of oxygen.
Properties of light propagation through tissue
The major challenges in optical imaging relate to the nature
of the interactions between light and matter, namely scatter-
ing and absorption. Upon contact with tissue, photons in
the visible and infrared wavelengths are highly scattered,
resulting in photon diffusion; that is, photons do not
propagate along straight lines but follow diffusive patterns.
Furthermore, the intensity of light is reduced after passing
through tissue. As a general rule, there is an approximate 10-
fold loss of photon intensity for each centimetre of tissue
depth (Contag et al., 1995). This absorption demonstrates
a characteristic spectral signature originating from endo-
genous chromophores. Within the visible spectrum
(400–760 nm), haemoglobin is the primary chromophore
that absorbs light within tissues (Taroni et al., 2003).
Haemoglobin absorbs in the blue and green part of the
visible spectrum, but its absorption of wavelengths longer
than 600 nm is reduced, allowing transmission of red light
Table 2. Commercially available BPI instrumentation
Manufacturer Instruments Features Specifications
Berthold Technologies
(http://www.bertholdtech.com)
NightOwl
(2 camera options)
Bioluminescence
Fluorescence
Various filters (340–1100 nm); tungsten
halogen excitation source.
Biospace Lab
(http://www.biospacelab.com)
PhotonImager Bioluminescence
Fluorescence
Macrolens to convert to
bioluminescence microscope
Image freely moving animals
(In Actios)
Excitation filters span 400–800 nm;
6 emission filters;
150W halogen excitation source
Caliper Life Sciences
(http://www.caliperls.com)
IVIS
(various models)
Bioluminescence
Fluorescence
Digital X-ray (Lumina XR)
Image freely moving animals
(Kinetic)
Excitation filters span 425–760 nm;
Various options for emission filters
spanning 500–875 nm; software for
3D reconstruction using spectral scanning
(not all models).
Cambridge Research &
Intrumentation (CRi)
http://www.cri-inc.com
Maestro Fluorescence
Spectral scanning
Liquid crystal tunable filter allows
spectral scanning
over range of 500–950 nm in
user-defined steps as small as 2 nm;
xenon excitation source
Carestream Health
(http://www.carestreamhealth.com)
Kodak In Vivo
Imaging systems
(various models)
Bioluminescence
Fluorescence
Digital X-ray (FX/FX-Pro)
Up to 28 excitation filters; 6 emission filters;
175W xenon excitation source
Li-Cor Biosciences
(http://www.licor.com)
Pearl (1 mouse);
Odysseys Imager1
MousepodTM (3 mice)
Near infra-red fluorescence Two-channel laser excitation
(excitation/emission filters):
685/720 nm and 785/820nm
VisEn
(http://www.visenmedical.com)
FMT 2500
Imaging system
Near infra-red fluorescence
Two modes: Reflectance
Imaging and
Quantitative Tomography
Multimodality adaptors
for CT/MR/PET
Two channel laser excitation
(excitation/emission filters):
670/700 nm and 745/780nm
UVP
(http://www.uvp.com)
iBoxs Scientia
Small Animal
Imaging System
(2 camera options)
Bioluminescence
Fluorescence
Eight excitation filter positions;
three emission filters:
515–570 nm, 485–655 nm, 570–640nm;
150W excitation source
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through several centimetres of tissue (Rice et al., 2001).
Melanin is also a significant contributor to absorption in
pigmented animals, meaning that signals within animals
with dark fur will be much more attenuated than signals
from within nude animals or those with white fur. Shaving
with clippers or removing fur with a depilatory agent can go
some way towards minimizing this problem.
These concepts can be easily demonstrated by holding a
flashlight behind your hand and observing the light emer-
ging through your fingers (Doyle et al., 2004). While light
can be observed to pass through the skin, muscle and bone,
clear images of the bones are not apparent due to the
scattering of photons as they bounce through the tissue.
Moreover, the light coming through the fingers is red. This is
due to the greater absorption of the shorter wavelengths of
light (blue and green) compared with the longer wave-
lengths (red light). While the spectral properties of the
photonic signal as well as its location within the body will
therefore have a significant impact on how much of the light
is transmitted to the surface, the optical properties of tissues
are predictable and can be modelled mathematically
(Cheong et al., 1990; Rice et al., 2001; Ripoll & Ntziachristos,
2003; Ripoll et al., 2003), allowing a certain degree of
quantification and resolution.
Background fluorescence/luminescence
In general, luminescence imaging is much more sensitive
than fluorescence imaging as a result of better signal-to-
noise ratios. This is mainly due to the high levels of
background fluorescence in vivo compared with lumines-
cence (Troy et al., 2004). Indeed, tissue autofluorescence is
one of the major causes for concern in imaging fluorescence,
and is due to endogenously produced fluorophores such as
keratin, porphyrins, NAD(P)H, collagen and elastin. Gen-
erally, autofluorescence from most materials, including
tissue, is higher at short wavelengths and decreases in the
red (Troy et al., 2004). Although the level of autofluores-
cence is dependent on the intensity and wavelength of the
excitation source, autofluorescence is generally many orders
of magnitude brighter than autoluminescence. Autofluores-
cence in the green and red-orange spectral regions is fairly
uniform over the entire animal. For the far-red and near-
infrared (NIR) spectral regions, tissue autofluorescence is
more concentrated in the intestinal area due to the presence
of chlorophyll in rodent diet (Troy et al., 2004). A number of
alternative diets are available, including an alfalfa-free diet
and a purified diet (containing predominantly cornstarch
and milk casein), both of which drastically reduce the levels
of background fluorescence in the red and NIR parts of the
spectrum in the abdominal region (Inoue et al., 2008). In
addition, advances in spectral unmixing algorithms have
improved the signal-to-noise ratio of fluorescent signals by
separating the specific signal from the autofluorescence.
Oxygen requirement
Oxygen is a cofactor required by all luciferases discovered to
date. However, it has been reported that luminescence can
be detected from marine bioluminescent bacteria under
oxygen concentrations as low as 10 nM (Bourgois et al.,
Table 3. Factors affecting the sensitivity of BPI
Sensitivity of the detection system
Level of fluorophore/luciferase expression
Wavelength of light emitted
Excitation wavelength (fluorescence)
Availability of cofactors
Location of the signal within the animal (tissue type and depth)
Whether the animal has fur or is pigmented
Background fluorescence/luminescence
0.5
1.0
1.5
2.0
x106
Photons s
–1cm
–2 sr
–1
(a) (b) (c) (d)
Fig. 2. Monitoring correct dosing using BPI. Mice were inoculated with luminescent Citrobacter rodentium ICC180 via the intraperitoneal route (a, b)
and by oral gavage (c, d), and the success of the administration was determined by BPI. The animals in (a) and (c) have been correctly dosed with
administration of the inocula delivered into the peritoneum (a) and gastrointestinal tract (c). The animals in panels (b) and (d) have been incorrectly
dosed, with the inocula being inadvertently delivered into the bladder (b) and lungs (d). Images were acquired using an IVIS system (Caliper Life Sciences)
with an integration time of 1 min and are displayed as pseudocolour images of peak bioluminescence, with variations in colour representing light
intensity at a given location. Red represents the most intense light emission, while blue corresponds to the weakest signal. The colour bar indicates
relative signal intensity (as photons s1 cm2 sr1).
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2001). Furthermore, chromophore maturation in almost all
FPs requires molecular oxygen, but is prevented only by
rigorously anoxic conditions (o 0.75 mMO2), and is readily
detected at 3mMO2 (Hansen et al., 2001). As a result of the
reliance upon oxygen for generation of a photonic signal, it
has been suggested that BPI may be of limited use in
anaerobic environments, such as the necrotic cores of large
tumours. While this is certainly an important consideration,
BPI can actually shed some light on how anaerobic these
environments are. For example, the presence of ‘strict’
anaerobes such as Bacteroides residing within the gastro-
intestinal tract has led to the long-held belief that this
environment is anaerobic. In fact, the tissues surrounding
the lumen of the gastrointestinal tract are oxygen rich, and
oxygen has been shown to diffuse into the intestine (He
et al., 1999). BPI has clearly demonstrated that this level of
oxygen is sufficient to allow the generation of detectable
light by a luminescent derivative of the enteric pathogen
Citrobacter rodentium colonizing the murine colon and
caecum (Wiles et al., 2006b). Furthermore, light production
was only seen in live animals, suggesting the requirement for
a circulating blood supply to provide sufficient oxygen. A
similar observation has been reported for Salmonella, with
luminescence in the caecum ceasing after cervical disloca-
tion of the animal (Contag et al., 1995), while Lane et al.
(2007) reported a waning of the bioluminescent signal
shortly after dissection for the bladder, and mincing of the
kidneys was necessary to replicate by ex vivo imaging the
signal observed in vivo. These diverse observations could be
related to variations in the oxygen concentrations in differ-
ent in vivo niches, as well as the inherent characteristics of
the microorganisms being studied. Importantly, it has been
demonstrated that aerobic respiration is required for com-
mensal and pathogenic Escherichia coli to colonize mice
(Jones et al., 2007) and that many species of Bacteroides can
grow in nanomolar concentrations of oxygen (Baughn &
Malamy, 2004). Indeed, homologues of cytochrome bd
oxidase (CydA), essential for oxygen consumption, have
been identified in the genomes of many prokaryotes classi-
fied as strict anaerobes (Baughn & Malamy, 2004). This has
led to the suggestion of a new term, nanaerobes, for such
organisms that can benefit from, yet do not require, oxygen
for growth. Perhaps a number of the environments pre-
viously thought to be anaerobic are nanaerobic.
Performing BPI
There are two main techniques for performing BPI: planar
imaging and tomographic imaging. Planar imaging is the
simplest method, being easy to implement and offering high
throughput. However, it does have limitations, most notably
the nonlinear relationship between the signal detected, its
location within the animal (depth) and the optical proper-
ties of the surrounding tissues. In contrast, tomographic
imaging enables quantitative three-dimensional volumetric
imaging but is more time-consuming and labour-intensive.
Planar imaging
Typically, a photographic reference image is first acquired
under weak illumination. In fluorescence imaging, this is
followed by illumination of the subject, usually with a broad
light beam passing through a filter tuned to the excitation
wavelength of the fluorophore of interest. Typically the light
source is located on the same side as the detector (known as
epi-illumination) but the light source may also be located on
the opposite side to the detector (known as trans-illumina-
tion). In general, trans-illumination is capable of imaging
signals located deeper within the tissue. The resulting
biophotonic signal is then captured in complete darkness,
which may take from seconds to minutes depending on the
strength and location of the signal and the sensitivity of the
imaging system. Again, the emitted light can be captured
using particular bandwidth emission filters. CCD cameras
spatially encode the intensity of incident photons, which are
then shown as a pseudocolour image superimposed on the
grey-scale photographic image. Bioluminescent signals are
detected in the same manner but without the second
illumination step. Typically, data are quantified by region-
of-interest analysis, measuring absorption units or efficiency
(the fraction of fluorescent photons relative to each incident
excitation photon) for fluorescence and photon flux for
bioluminescence.
Importantly, the properties of tissue attenuation pre-
viously discussed mean that images are surface-weighted;
light sources closer to the surface of the animal appear
brighter compared with those in deeper tissue, highlighting
the need for further information regarding signal localiza-
tion. This may take the form of pilot experiments in which
tissues are harvested after imaging to determine the location
of the photonic signal. Hillman &Moore (2007) developed a
novel system for aiding localization, which they termed
dynamic fluorescence molecular imaging. The technique
involves acquiring a series of dynamic (time-sequence)
images following a tail-vein injection of an NIR dye. As the
dye circulates throughout the body, each organ displays
characteristic and visible pharmacokinetics. This system is
now marketed by CRi (http://www.cri-inc.com) as Dynamic
Contrast Enhancement (DyCE) for use with the Maestro
imaging system (Table 2). Essentially, the system resolves the
data using a series of algorithms and displays the organs in
pseudocolour; for example, the brain may appear as blue,
the liver as red, while the kidneys in purple.
Advanced understanding of the depth-dependent at-
tenuation of light at different wavelengths and the develop-
ment of mathematical models now allows the generation of
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a three-dimensional reconstruction of bioluminescent/
fluorescent sources from a series of planar images. For
example, diffuse luminescence tomography is based on the
acquisition of a photographic image, followed by a struc-
tured light image to reconstruct the tomography of the
surface of the subject. A number of images are then acquired
using two or more narrow band-width emission filters and
the data are combined to produce a high-resolution map of
the photon density at the surface. The reconstruction
algorithm then consists of finding an approximate solution
to a system of linear equations that relate the source strength
at each point inside the object to the photon density at the
surface (Kuo et al., 2007).
Tomographic imaging
True tomographic imaging has mainly been applied to
imaging fluorescence (also referred to as FMT), and involves
the illumination of the sample at different points or projec-
tions and the collection of the emitted photonic signal using
various photodetector sets or a CCD camera. As with planar
imaging, the emitted light can be captured using particular
bandwidth emission filters. There are three distinct methods
by which the tissue can be illuminated: using light of
constant intensity [termed constant wave (CW)], using light
of modulated wavelength [termed frequency domain (FD)]
or using ultrafast (femtosecond to picosecond) photon
pulses and resolving the arrival of the photons as a function
of time [termed time-domain (TD)]. Each method has
distinct advantages and disadvantages, and selection largely
depends on the specific application (Ntziachristos et al.,
2005). Importantly, each source–detector pair effectively
implements a different projection through the tissue and
this is combined with mathematical formulae that describe
photon propagation in tissues as well as algorithms for
image reconstruction. Increasing the number of source–de-
tector pairs increases the accuracy of the reconstructed
image. Recently, Turner et al. (2005) reported the rotation
of an object of interest in front of the illumination path,
using a CCD camera to collect up to 72 projections. Termed
complete projection tomography, the authors demonstrated
the ability to resolve both the location and size of the
photonic signal. More comprehensive descriptions of FMT
can be found in a number of recent reviews (Ntziachristos
et al., 2005; Ntziachristos, 2006).
Performing such tomographic analyses of bioluminescent
sources can be carried out in a similar fashion but in the
absence of external illumination (Gu et al., 2004; Wang et al.,
2004a). However, the lack of external illumination makes it
mathematically more difficult to resolve the photonic signal
as there are fewer projections (source–detector pairs) avail-
able. Furthermore, as the bioluminescent signal is continu-
ously on during the measurement, bioluminescence
tomography operates in CW mode only. For these reasons,
as well as the recent withdrawal of the only commercially
available system capable of rotating the animal and captur-
ing multiple projections, such tomographic reconstruction
of bioluminescent sources is rare.
Animal welfare during BPI
To perform BPI, animals are most often anaesthetized for
restraint purposes, using either gaseous or injectable anaes-
thetic agents. Furthermore, if generation of a photonic
signal is dependent upon the addition of exogenous sub-
strate, this must be administered by an appropriate route.
The two main implications for animal welfare therefore
relate to anaesthesia and the number and frequency of
injections.
Anaesthesia
There are a number of factors that will influence the type of
anaesthetic agent selected for BPI, including the animal
species and strain, the time required to remain under
anaesthesia and the equipment available. Both the type of
imaging being performed (planar vs. tomographic) as well
as the level of photonic signal will determine the period of
time required for the animals to remain under anaesthesia,
usually in the range of 1–30min. As mice cannot regulate
their own body temperature under anaesthesia, steps should
be taken to maintain their core temperature both during
imaging and until full recovery. In most commercial ima-
ging systems, the shelf of the imaging chamber is heated for
exactly this reason. It is preferable to anaesthetize mice using
inhalational agents such as isoflurane, as the depth and
duration can be more easily controlled and standardized.
Inhaled agents are mainly eliminated by the lungs, whereas
injectable agents need to be metabolized by the liver and
excreted by the kidneys, a process that can be prolonged.
Recovery is therefore more rapid from inhaled agents, which
is important in regaining normal physiology, to control
postprocedural hypothermia and fluid or electrolyte imbal-
ance. Inhalational agents are also suitable for high-frequency
anaesthesia studies, where animals are repeatedly imaged.
For example, mice can be imaged three to four times a day
using isoflurane although ideally this intensive monitoring
regime would not be followed for more than 3 days. Where
injectable agents are used, each animal should be weighed
and dosed according to its bodyweight. Ketamine can cause
muscle rigidity, and so in certain situations the mice may
appear to twitch. This is less than ideal, especially if the
photonic signal is located in the limbs. Anaesthetized
animals must be monitored to ensure that they remain in
the proper anaesthetic plane. The animals should not be too
lightly anesthetized that they regain consciousness, or too
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deep that vital functions are compromised. For prolonged
periods of anaesthesia (4 30min), it is recommended to
use an ophthalmic artificial tear ointment such as Lacrilube
(Allergan, Buckinghamshire, UK) to prevent corneal drying
and trauma.
Number and frequency of injections
In accordance with the ethical responsibilities placed on
researchers using animals, there are published good practice
guidelines on the total number and frequency of injections
that can be administered to an animal (Diehl et al., 2001).
For BPI, this limits the number of imaging sessions that can
be performed on an animal throughout an experiment,
particularly if injectable anaesthetic agents and substrate
are administered. Suggested maximum doses and frequen-
cies for mice are given in Table 4.
Generation of a photonic signal for BPI
As stated previously, the biophotonic signal detected during
BPI can be either bioluminescent or fluorescent. In this
section, we describe the basic properties of these two very
different phenomena.
Bioluminescence
Bioluminescence is widely distributed in nature, occurring
in a remarkably diverse set of organisms, including bacteria,
dinoflagellates, fungi, fish, insects, shrimp and squid. Biolu-
minescence arises from the oxidation of a substrate (a
luciferin) by an enzyme (a luciferase), which usually requires
energy (in the form of FMNH2 and ATP) and oxygen.
Luciferin and luciferase are generic terms as none of the
major classes share sequence homology. While phylogenetic
analyses suggest that bioluminescence has had more than 30
independent origins, there are five basic luciferin–luciferase
systems. Most widely studied of the bioluminescence systems
are those belonging to luminous beetles in the family Lampyr-
idae (the most studied being the firefly Photinus pyralis and
the click beetle Pyrophorus plagiophtalamus), the sea pansy
Renilla reniformis, the marine copepod Gaussia princeps and
numerous luminous bacteria (terrestrial Photorhabdus lumi-
nescens and marine Vibrio and Photobacterium sp.).
The beetle luminescence reaction is catalysed by a mono-
meric luciferase of approximately 62 kDa encoded by a
single gene (luc) and involves the oxidation of a benzothia-
zoyl-thiazole ‘luciferin’ (commonly referred to as luciferin)
and ATP, resulting in the production of oxyluciferin, AMP,
CO2 and the emission of light. In P. pyralis this light has a
peak at 560 nm (Hastings, 1996) while P. plagiophtalamus
emits light of distinct peaks, ranging from 546 to 593 nm
(Wood et al., 1989). Interestingly, the light generated by the
firefly luciferase is influenced by temperature, shifting to a
peak of 610 nm at 37 1C (Zhao et al., 2005a). The firefly
luciferase catalyses the most efficient bioluminescent reac-
tion known (i.e. the amount of light generated in relation to
the energy expended) with a quantum efficiency of 0.41
(Ando et al., 2007) and tends to be the reporter of choice for
expression by eukaryotic cells. The genes required for
luciferin production have not been completely elucidated
and therefore exogenous luciferin must be administered by
an appropriate route, most commonly via intraperitoneal
injection, a few minutes before imaging. Fortunately, at the
doses administered, luciferin does not appear to be toxic to
animals and rapidly distributes throughout the mouse
(Contag et al., 1997), crossing the blood–brain and placental
barriers (Lipshutz et al., 2001; Rehemtulla et al., 2002).
Furthermore, as it is given in excess, substrate availability is
not generally considered to be a limiting factor. Recently, it
has been suggested that if luciferin is not required to be
distributed throughout the animal, it can be directly injected
into specific sites of interest instead. Researchers have
utilized this delivery method to image luciferase expression
in muscle, the knee joint (Bloquel et al., 2006) and the
vaginal tract (Doyle et al., 2006a). Furthermore, Buckley
et al. (2008) demonstrated that when imaging in the nasal
and pulmonary airways of mice, compared with intraper-
itoneal injection, intranasal instillation yields about a 10-
fold increase in sensitivity with an approximate 30-fold
reduction in luciferin usage. Alternative methods of lucifer-
in delivery have been described in the literature and include
the use of an osmotic pump for continuous delivery (Gross
et al., 2007), encapsulation of the luciferin within long
circulating liposomes (Kheirolomoom et al., 2010) or within
food and water (Hiler et al., 2006).
The monomeric sea pansy and copepod luciferases,
encoded by the genes rluc (also referred to as ruc) and gluc,
respectively, are members of the most common natural
bioluminescence system, deep-sea imidazolopyrazine biolu-
minescence, which has been reported in seven phyla
and approximately 90 genera (Thomson et al., 1997).
Table 4. Suggested maximum volumes and frequencies of administra-
tion of substances to mice (in accordance with Diehl et al., 2001)
IP IM SC IV
Maximum number
of doses
24 6 24 14
Maximum daily volume 20mL kg1 500mL 20mL kg1 10mL kg1
Number of daily doses
o 7 days
2–3 2 3 1–2
Number of daily doses
47 days
1 1 2 o 1
For intravenous administration, 1 dose per day should be administered
for no more than 6 days, while 2 doses per day should be administered
for no more than 2 days.
IP, intraperitoneal; IM, intramuscular; SC, subcutaneous; IV, intravenous.
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Coelenterazine is an imidazolopyrazine derivative that acts
as the luciferin that, when oxidized by the appropriate
luciferase, produces carbon dioxide, coelenteramide and
light in the blue part of the spectrum (480 nm) (Shimomura
et al., 1978; Shimomura & Teranishi, 2000). Interestingly,
Gluc is strongly resistant to heat and extreme pH (Wiles
et al., 2005b), and has been shown to be secreted from both
mammalian and bacterial cells (Tannous et al., 2005; Andreu
et al., 2010). However, the requirement for coelenterazine is
an important limiting factor in using Gluc and Rluc. As with
luciferin, coelenterazine has to be administered by an
appropriate route, most often by tail-vein injection. In
contrast to luciferin, the bioavailability of coelenterazine is
limited in vivo, at least in part by the multidrug resistance P-
glycoprotein (MDR1), which transports coelenterazine and
similarly structured compounds out of the membranes of
mammalian cells (Pichler et al., 2004). Furthermore, coe-
lenterazine is highly chemiluminescent, undergoing lucifer-
ase-independent oxidation (Shimomura & Teranishi, 2000),
thus limiting sensitivity by reducing the signal-to-noise
ratio. Indeed, we have been unable to distinguish in vivo
the signal from Gluc-expressing Mycobacterium smegmatis
from the strong background produced by the coelenterazine
substrate alone (Andreu et al., 2010). Nevertheless, BPI of
tumour cells expressing Gluc and Rluc has been reported
(Bhaumik & Gambhir, 2002; Tannous et al., 2005).
The bacterial luminescence reaction involves the oxida-
tion of a long-chain aldehyde and reduced flavin mono-
nucleotide (FMNH2) resulting in the production of oxidized
flavin (FMN), a long-chain fatty acid and light at 490 nm
(Hastings & Presswood, 1978; Baldwin et al., 1984; Camp-
bell, 1989). The reaction is catalysed by bacterial luciferase, a
heterodimeric enzyme of 77 kDa composed of an a and a b
subunit encoded by the luxA and luxB genes, respectively.
The luxC, D and E genes encode the subunits of a multi-
enzyme complex responsible for regeneration of the alde-
hyde substrate from the fatty acid produced by the reaction.
A significant advantage of the bacterial luciferase system is
therefore the ability to express the biosynthetic enzymes for
substrate synthesis.
Fluorescence
The phenomenon of fluorescence was first described in 1845
by John Frederick William Herschel, who observed a super-
ficial blue glow in a solution of quinine in the sunlight
(Herschel, 1845). The intervening years have now seen FPs
and probes used ubiquitously in biological research. Irradia-
tion of a fluorescent compound with light of a suitable
wavelength leads to the transition of an electron in the
molecule to a higher energy state (excitation). This process
is almost instantaneous, taking around 1015 s. Upon return
of the electron to a lower energy level (around 10 ns), light of
lower energy is emitted, giving the fluorescent signal.
Because lower energy light is emitted, it is red-shifted in the
spectrum when compared with the excitation light, a
phenomenon known as the Stokes shift.
FPs
Green fluorescent protein (GFP) from the jelly fish Aequorea
victoria was first described in 1962 by Osamu Shimomura
(Shimomura et al., 1962; Shimomura, 2005) who was
awarded the 2009 Nobel Prize in Chemistry for his discov-
ery, together with Roger Tsien and Martin Chalfie. In the 15
years since Chalfie first reported the use of GFP as a marker
of gene expression in the nematode Caenorhabditis elegans
(Chalfie et al., 1994), numerous FPs in all colours of the
rainbow have been discovered and developed, many of them
in Roger Tsien’s lab. Most FPs derived from GFP have
emission peaks in the blue, green or yellow range of the
spectrum. To date, the only exception is R10-3, a dual
emitting FP with emission peaks at 555 and 585 nm (Mishin
et al., 2008). Red FPs are often based on proteins from other
sea organisms, such as DsRed from the coral Discosoma sp.
The FP family is constantly expanding; over 40 coral FPs
were described recently by Alieva et al. (2008), which range
in colour from cyan to chromored, while the ‘mFruit’
variants of red FPs were developed by Shaner et al. (2004).
For a fluorescent marker to be successfully used for BPI, it
has to fulfil several criteria including suitable excitation and
emission wavelengths, photostability (a measure of the time
an FP takes to lose 50% of its initial emission, under
constant illumination), brightness and maturation speed
(the time taken to full chromophore formation). The
brightness of an FP is proportional to the product of its
quantum yield and extinction coefficient. The quantum
yield is the ratio of the number of emitted photons to
absorbed photons, while the molar extinction coefficient
describes the amount of light absorbed by a 1M solution of
the protein at a path-length of 1 cm at a given wavelength
(M1 cm1). Because light penetration of tissue depends
heavily on wavelength, with longer wavelengths (ideally
4 650 nm) being more efficient (as discussed earlier), we
focus on fluorescent molecules whose emission are in the
red or the far red end of the spectrum, which are most
suitable for BPI (Table 5). Excellent reviews on the topic of
FPs in general can be found elsewhere (Shaner et al., 2005,
2007; Remington, 2006; Pakhomov & Martynov, 2008).
In the last few years, several groups of new red FPs have
been reported. Based on DsRed, mRFP1 was the first
monomeric red fluorescent protein (RFP) reported (Camp-
bell et al., 2002). This protein was then subjected to
molecular-directed evolution, which resulted in several new
FPs, ranging in colour from yellow to dark red (the
‘mFruits’; Shaner et al., 2004). The most notable of these
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are tdTomato and mCherry. Even though the excitation and
emission spectra for tdTomato (554 and 581 nm, respec-
tively) are slightly lower than would be ideal for BPI, its
exceptional brightness (160% of the original DsRed), fast
maturation and high photostability make it a candidate
worth considering. mCherry, the only protein in this study
that emits light at a wavelength over 600 nm, is less bright
(27% of DsRed) but similarly fast maturing and photo-
stable. In our experiments, both proteins are well-expressed
in E. coli, M. smegmatis, and Mycobacterium tuberculosis
after codon optimization (Carroll et al., 2010). Wang et al.
(2004b) used iterative somatic hypermutation to create two
further far-red-emitting monomeric FPs, mRaspberry and
mPlum. In this elegant approach, the gene for mRFP1.2 was
expressed in a human B cell line and mutants were selected
for their brightness and red-shifted emission using fluores-
cence-activated cell sorting. As a result, mRaspberry displays
excitation and emission maxima at 598 and 625 nm, respec-
tively, with a maturation time similar to tdTomato. While
the long excitation and emission wavelengths appear pro-
mising, this FP shows only 22% of the brightness of DsRed,
and low photostability with 50% of emission intensity lost
after only 14 s. Conversely, the furthest red-emitting protein
in the mFruit series, mPlum (emission at 649 nm), takes 80 s
to lose half its emission intensity, but displays o 10% of the
brightness of DsRed.
Another group of proteins emerged from two FPs isolated
from the sea anemone Entacmaea quadricolor, eqFP578 and
eqFP611 (Wiedenmann et al., 2002; Merzlyak et al., 2007;
Shcherbo et al., 2007, 2009; Kredel et al., 2008, 2009). Both
are characterized by relatively high brightness and a reduced
tendency to oligomerize as compared with DsRed, which in
its original configuration forms tetramers. Merzlyak et al.
(2007) used the dimer-forming eqFP578 as a basis to
perform random mutagenesis with the aim to optimize
maturation time while maintaining brightness and a red
colour. The resulting TurboRFP displays excitation and
emission peaks of 553 and 574 nm, respectively, fast matura-
tion at 37 1C, high pH stability, and brightness comparable
to DsRed. Using site-directed mutagenesis, they then devel-
oped a monomeric version of TurboRFP called TagRFP. This
protein has slightly red-shifted excitation and emission
maxima (555 and 584 nm, respectively), but is somewhat
less bright; a more photostable version (TagRFP-T) is also
Table 5. Characteristics of the fluorescent proteins deemed most suitable for BPI
Fluorescent
protein
Excitation
max.
Emission
max. Origin
Quantum
yield
Excitation
coefficient
(M1 cm1)
Brightness
(% DSRed)
Maturation t1/2
(min) Reference
DsRed 558 583 Discosoma sp. 0.79 75000 100 600 Shaner et al. (2004)
tdTomato 554 581 DsRed 0.69 138 000 160 60 Shaner et al. (2004)
mCherry 587 610 DsRed 0.22 72000 27 15 Shaner et al. (2004)
mRaspberry 598 625 DsRed 0.15 86000 22 55 Wang et al. (2004b)
mPlum 590 649 DsRed 0.1 41 000 7 100 Wang et al. (2004b)
TurboRFP 553 574 eqFP578 0.67 92000 104 ND Merzlyak et al. (2007)
TagRFP 555 584 eqFP578 0.48 100 000 81 100 Merzlyak et al. (2007)
Katushka 588 635 eqFP578 0.34 65000 37 20 Shcherbo et al. (2007)
mKate 588 635 eqFP578 0.28 31500 15 75 Merzlyak et al. (2007),
Shcherbo et al. (2007)
tdKatushka2 588 633 eqFP578 0.37 132 500 82 ND Shcherbo et al. (2009)
mKate2 588 633 eqFP578 0.4 62 500 42 o 20 Shcherbo et al. (2009)
RFP611 559 611 eqFP611 0.48 120 000w 97w 110 Kredel et al. (2008)
151 000z 122z
RFP639 588 639 eqFP611 0.18 69.000w 21w 90 Kredel et al. (2008)
110 400z 34z
tdRFP611 558 609 eqFP611 0.47 70 000w 56w 225 Kredel et al. (2008)
144 000z 114z
tdRFP639 589 631 eqFP611 0.16 90 400w 24w o 480‰ Kredel et al. (2008)
110 000z 30z
mRuby 558 605 eqFP611 0.35 112 000w 66 168 Kredel et al. (2009)
AQ143 595 655 aeCP597 0.04 90000 6 ND Shkrob et al. (2005)
IFP1.4 684 708 DrBphP 0.07 92000 11 ND Shu et al. (2009)
Key:
Brightness is calculated as extinction coefficientquantum yield.
wAs determined by alkaline denaturation method.
zAs determined by dynamic difference method.
‰As determined from expression in HEK293 cells; ND, not determined.
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available (Shaner et al., 2008). With the aim of developing a
bright, far-red protein for whole-body imaging, Shcherbo
et al. (2007) used a combination of site-specific and random
mutagenesis to TurboRFP and several of its precursors. A
library of 100 000 clones was screened for high brightness
specifically at emission wavelengths of 4 650 nm. A red-
shifted variant of TurboRFP was selected and further
optimized, yielding the final product Katushka. At 635 nm,
the emission of Katushka is further red shifted in compar-
ison with mCherry, while the excitation peaks of the two
proteins are very similar. Furthermore, Katushka matures
faster, is more photostable, and is 1.4 times brighter than
mCherry, making it an excellent candidate for BPI provided
its dimeric state is tolerated by the host cell. Whole-body
imaging of transgenic Xenopus laevis clearly showed super-
ior tissue penetration of light when using Katushka; mPlum
was also expressed but could hardly be detected, underlining
the importance of brightness of an FP as well as wavelength
characteristics. Because Katushka is dimeric, the authors
also applied the mutations that gave rise to the monomeric
protein TagRFP (Merzlyak et al., 2007), resulting in mKate.
This protein has spectral properties very similar to Katush-
ka, but its maturation (half time of 75min) and pH stability
are inferior, although the brightness level is comparable to
that of mCherry. In an effort to improve the brightness of
far-red FPs, the same group recently reported mKate2, an
enhanced version of mKate, and tdKatushka2, a tandem
dimer version of Katushka (Shcherbo et al., 2009), which
display two- to almost threefold increased brightness over
their respective precursors.
The second protein isolated from E. quadricolor, eqFP611
(Wiedenmann et al., 2002), has given rise to a number of
variants emitting in the far red, as described by Kredel et al.
(2008, 2009). EqFP611 in its natural form is characterized by
a far-red emission peak at 611 nm, a large Stokes shift of
52 nm and low aggregation tendency. However, this protein
only folds efficiently at temperatures o 30 1C and its use
in vivo in mammalian systems is therefore limited. Using
combined directed and random mutagenesis approaches,
the researchers generated several variants of eqFP611, the
two most interesting being RFP611 and RFP639, where the
number indicates the emission maximum of each protein.
Both proteins show good folding properties at 37 1C and
high brightness. RFP611 has an excitation maximum of
559 nm and is 3.6 times brighter than mCherry, although its
maturation time is slower at a half time of 1.83 h, and it is
slightly less photostable (Kredel et al., 2008). The excitation
peak of RFP639 is at 588 nm, which makes its spectral
properties similar to those of mCherry, with the brightness
levels of both proteins being similar. RFP639 is approxi-
mately three times more photostable but has a longer
maturation half time (1.5 vs. 0.25 h for mCherry). Because
both RFP611 and RFP639 have a tendency to form tetra-
mers, tandem-dimeric versions of each protein were de-
scribed in the same study, with only slightly different
spectral properties (Kredel et al., 2008). mRuby, a mono-
meric version of RFP611, was recently presented and is
characterized by excitation and emission peaks at 558 and
605 nm, respectively (Kredel et al., 2009). It displays a fairly
long maturation time (half time of 2.8 h) and is 1.5 times
brighter than mCherry as measured by the authors, but is
slightly less photostable. It is also extremely pH stable.
One FP that reaches the 650-nm barrier of emission is
AQ143 (Shkrob et al., 2005). This protein was derived from
a blue nonfluorescent chromoprotein of the beadlet ane-
mone Actinia equine (aeCP597) after random and site-
specific mutagenesis. Its excitation and emission maxima
are at 595 and 655 nm, respectively, which is the furthest
red-shifted FP reported so far. However, like other far-red-
emitting proteins (e.g. mPlum), it suffers from low bright-
ness. Recently, Shu et al. (2009) demonstrated a new
approach for engineering an infrared fluorescent protein
for BPI using a truncated form (DrCBD) of the bacterio-
phytochrome DrBphP from Deinococcus radiodurans. The
authors demonstrated that DrCBD, which consists of only
the chromophore-binding domain, incorporates biliverdin,
an intermediate in haeme catabolism produced by haeme
oxygenase (HO-1), as the chromophore. The first variant,
IFP1.0, was coexpressed with cyanobacterial HO-1 in E. coli
and produced infrared fluorescence with an emission max-
imum at 722 nm. This protein was then subjected to
mutagenesis and directed evolution, giving rise to further
improved variants IFP1.1–IFP1.4, the latter of which is
characterized by excitation and emission maxima of 684
and 708 nm, respectively, but suffers from low brightness
similar to mPlum and other far-red proteins, and low
photostability (50% bleaching after 8.4 s). However, after
intravenous infection of mice with an adenovirus construct
carrying the gene for either IFP1.1 or mKate, fluorescence
from IFP1.1 could be readily detected in the livers of
transfected mice after injection of the cofactor biliverdin.
Low mKate fluorescence could also be detected, which was
improved after removal of the overlying tissues (skin and
peritoneum). Considering that mKate and IFP1.1 are of
similar brightness, this once again demonstrates that tissue
penetration and brightness both play important roles when
choosing an appropriate fluorescent marker for BPI.
Alternatives to FPs
Although genetically encoded markers are very useful for
imaging of preclinical animal models, their construction
involves substantial time and resource commitments for
each individual microorganism of interest, and they are not
applicable in clinical settings. Leevy et al. (2006, 2008b) have
suggested the use of an injectable NIR probe consisting of a
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bacterial affinity group conjugated to an NIR dye as an
alternative. The researchers used a synthetic zinc(II) coordi-
nation complex [zinc(II)dipicolylamine or Zn-DPA], which
targets the anionic surfaces of bacterial cells in general,
linked to an NIR carbocyanine fluorophore with an excita-
tion wavelength of 794 nm and emission wavelength of
810 nm; synthesis of this probe is described in Leevy et al.
(2006). The authors demonstrated the ability of the probe to
target Staphylococcus aureus in a mouse leg infection model,
where 5 107 bacteria were visualized by noninvasive in vivo
imaging after intramuscular injection into the posterior leg
and intravenous application of the NIR probe (Leevy et al.,
2008a). Even though this is a promising proof-of-principle
study, the site of infection is isolated, shallow, well-separated
from major organs, and displays low inherent background.
Imaging of bacteria in deeper tissues with higher back-
ground fluorescence could, however, prove more difficult,
and reduce sensitivity so that bacterial numbers of 108 or
more in a defined space would be needed, which only occurs
in advanced stages of infection.
In recent years, quantum dots (QDs) have received some
attention as probes for BPI, especially in cancer research (a
short overview is given in Bentolila et al., 2009). QDs are
small fluorescent nanocrystals (usually a few tens of nan-
ometers), which are made of inorganic semiconductor
materials. They possess remarkable optical properties such
as extremely high brightness and photostability, wide ex-
citation and narrow emission spectra. What makes them
most interesting for BPI is the fact that their emission
wavelength depends on their size and can therefore be
manufactured and fine-tuned as needed, from the UV to
the infrared. However, using the previously described Zn-
DPA bacterial affinity probe coupled to highly fluorescent
QDs with an emission maximum of 800 nm via a biotin/
streptavidin linker, Leevy et al. (2008a, b) found that the size
of the QDs inhibited binding of the probe to its target on the
bacterial surface and abolished staining capabilities of the
probe in the case of S. aureus and two smooth strains of E.
coli. Yet a rough mutant of E. coli could be successfully
labelled, apparently owing to the lack of branched O-antigen
components of the lipopolysaccharide on the cell surface,
which prevent the Zn-DPA/QD complex from binding to its
lipid A target deeper in the membrane. When 108 prelabelled
rough E. coli were injected into the hind leg of a nude mouse
and the animal was imaged, the signal-to-noise ratio im-
proved when compared with labelling with the Zn-DPA/
NIR probe alone.
Even though autofluorescence is decreased with NIR
emission wavelengths, tissue absorption and scattering still
impede the amount of excitation light that reaches the
fluorophore inside the tissue, particularly because QDs
efficiently absorb blue light. To circumvent this problem,
So et al. (2006a, b) have created so-called ‘self-illuminating’
QDs in which commercially available QDs were coupled to
the Renilla luciferase (Luc8; Loening et al., 2006). Once the
luciferase is presented with its substrate coelenterazine, the
produced broad-spectrum blue light is transferred to the
QDs by bioluminescence resonance energy transfer, which
in turn leads to emission of light by the QDs in the red to
NIR part of the spectrum, depending on the QD used. By
completely eliminating the need for excitation light, the
signal-to-noise ratio was increased in some instances to
4 103 after injection of the luc8/QD complex into nude
mice. This very elegant approach could be refined by
combining different luciferases with QDs of different wave-
lengths. If a reliable method can be found to specifically
detect and label bacteria with QDs, this could be a very
advantageous and efficient methodology for the in vivo
imaging of bacterial infections.
Developing bioluminescent/fluorescent
microorganisms
The development of vectors for conferring a genetically
encoded bioluminescent/fluorescent phenotype onto micro-
organisms allows the monitoring of any population pro-
vided the reporter genes are sufficiently and stably expressed
and do not alter the ecological fitness and competitiveness of
the host species. These issues should be addressed separately
for each host/marker combination; genetic constructs
should be optimized to achieve the highest possible expres-
sion levels without toxicity or effects on virulence.
Stable reporter gene expression
Integration of the reporter gene onto the chromosome is
favourable over expression from a plasmid to ensure stable
and homogenous expression levels throughout the micro-
bial population and remove the need for antibiotic selection
often required to maintain plasmids. Such antibiotic pres-
sure would not be available in vivo and hence the use of a
plasmid may lead to the loss of the photonic signal during
infection. Until recently, the most popular means of inte-
grating reporter genes into the chromosome has been the
use of transposons, such as the mini-Tn5 derivatives devel-
oped by Winson et al. (1998) for use in Gram-negative
bacteria and the Tn4001 derivative developed by Francis
et al. (2001) for use in Gram-positive bacteria. Using this
strategy, transposon mutant pools are obtained and
screened for derivatives with high expression of the reporter
gene of interest, and which remain pathogenic (Francis
et al., 2001; Kuklin et al., 2003; Park et al., 2003; Wiles
et al., 2004; Kadurugamuwa et al., 2005b; Rajashekara et al.,
2005). While successful, this strategy can be extremely
labour-intensive and is very reliant on the use of appropriate
models to screen for attenuation. Furthermore, lack of
attenuation in one model does not necessarily exclude a
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gene from playing a role in other models. Recently, Riedel
et al. (2007a) constructed a novel vector (p16Slux), contain-
ing a temperature-sensitive Gram-positive origin of replica-
tion and a region of homology to the 16S rRNA gene. Using
this construct, the authors were able to develop biolumines-
cent strains of E. coli, Salmonella enterica, Enterobacter
sakazakii, Shigella flexneri, Yersinia enterocolitica and Pseu-
domonas aeruginosa. Furthermore, no differences were
observed in bacterial load in the organs of mice infected
with C. rodentium, S. enterica serovar Typhimurium and
P. aeruginosa tagged using p16Slux and the wild-type strains
(Riedel et al., 2007a). Unfortunately, this strategy was
unsuccessful in a number of Gram-positive bacterial species,
suggesting that Gram-positive bacteria are more sensitive to
the disruption of a copy of the 16S rRNA gene. Although not
yet widely used, an alternative approach exploits bacter-
iophage integrase genes and attachment sites to direct the
site-specific, single-copy integration of vectors into the
bacterial chromosome. This system has the advantage of
using previously characterized integration sites known not
to affect bacterial virulence in defined models, and has been
successfully used in S. aureus, Listeria monocytogenes andM.
tuberculosis (Bron et al., 2006; Steinhuber et al., 2008;
Andreu et al., 2010). Finally, another strategy being pursued
involves mining the genome for apparently ‘null’ sites. Such
sites may be identified by their apparent redundancy, a lack
of homology to known virulence factors or by a lack of
expression during in vivo microarray studies. However, it is
important to note that such a strategy may have unexpected
consequences. There are many genes with no ascribed
function that may play a role during infection. Likewise,
lack of expression in microarray studies does not necessarily
exclude a gene from being involved in models other than the
one in which the studies were undertaken.
Selection of an appropriate reporter
The suitability of a given reporter gene for developing
bioluminescent/fluorescent microorganisms will depend on
numerous factors. If a fluorescent phenotype is desired, the
FP will have to fulfil several criteria including suitable
excitation and emission wavelengths, photostability, bright-
ness, and maturation speed. It should be noted that for
whole-body imaging, it is often not essential that the FP is
available as a monomer; this is mostly imperative for cell
biology applications where the FP is used as a tag for another
protein. If oligomerization is tolerated by the host expres-
sing the reporter gene, tandem dimers might be preferred
because of often higher brightness.
If a luminescent phenotype is desired, the choice of
luciferase system will largely depend on the microorganism
of interest. A significant advantage of the bacterial luciferase
system (lux) is the ability to express the enzymes for
substrate synthesis, thus avoiding the need for exogenous
addition of substrate. Despite this inherent advantage, the
lux operon has remained almost exclusively used in bacteria,
with almost all other microorganisms being labelled with
genes encoding for eukaryotic luciferases (Table 6). The
exception to this is the yeast Saccharomyces cerevisiae, which
has been rendered bioluminescent using the lux operon
(Gupta et al., 2003). However, this required coexpression of
the frp gene from Vibrio harveyi, encoding an NADPH-FMN
oxidoreductase, to generate a detectable signal above back-
ground.
Of the lux operons cloned to date, that of P. luminescens is
ideally suited for in vivo use as the luciferase has an optimum
temperature range that lies within the body temperature of
mammalian tissues (Szittner & Meighen, 1990). However, in
general, it is not well-expressed by Gram-positive bacteria
and modified versions are available in which the operon has
been reorganized (luxABCDE) and Gram-positive ribo-
some-binding sites inserted (Francis et al., 2000; Qazi et al.,
2001). Furthermore, Craney et al. (2007) reported the
construction of a synthetic lux operon, codon optimized for
expression in high-GC bacteria such as Streptomyces sp.
It is important to note that bioluminescence from lux- and
luc-expressing microorganisms is related to an organism’s
metabolic activity. This is due to the reliance of the luciferases
on microbial metabolites, mainly FMNH2 and ATP, respec-
tively. This is exemplified by the decrease in the luminescence
that has been observed when many lux-expressing bacterial
species enter stationary phase during in vitro growth (Francis
et al., 2001; Hardy et al., 2004; Wiles et al., 2004). A similar
finding has been reported for lux-expressing Leishmania
amazonensis (Lang et al., 2005) and M. smegmatis (Andreu
et al., 2010). Although this could represent a handicap for the
study of, for example, dormant microorganisms in vivo, it can
also be a powerful tool to gain insights into an organism’s
metabolic state during infection, as well as for the rapid
detection of drugs that act on metabolism. In contrast, the
bioluminescence of Gluc-expressing cells appears to be inde-
pendent of cofactors that become limited during stationary
phase (Wiles et al., 2005b; Andreu et al., 2010).
Maximizing detection limits
It is clear from the published literature that the in vivo limits
of detection of labelled microorganisms vary considerably;
this will be the result of a combination of numerous factors
(Table 3). Glomski et al. (2007b) reported that the detec-
tion limits for lux1 B. anthracis using the IVIS100 system
(Xenogen, now part of Caliper Life Sciences, Alameda) were
between 103 and 105 bacteria in different organs, and were a
reflection of differences in organ location and pigmentation.
Similarly, using the Xenogen IVIS50 system, Wiles et al.
(2004) found the detection limits for lux1 C. rodentium to
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be approximately 103 bacteria within a foci. These limits are
likely to improve as the sensitivity of the imaging systems
improves.
However, as molecular microbiologists developing fluores-
cent/bioluminescent microorganisms, there are a number of
factors that are somewhat within our control, namely: (1)
Table 6. Noninvasive imaging studies utilizing bioluminescent microorganisms
Microorganism Reporter Reference
Bacteria
Bacillus anthracis lux Glomski et al. (2007a, b), Sanz et al. (2008), Crawford et al. (2009), Loving et al. (2009)
Bifidobacterium breve lux Cronin et al. (2008)
Brucella melitensis lux Rajashekara et al. (2005, 2006), Radhakrishnan et al. (2009)
Burkholderia pseudomallei lux Owen et al. (2009)
Citrobacter rodentium lux Wiles et al. (2006b, 2007, 2009), Bishop et al. (2007), Gibson et al. (2008, 2010),
Riedel et al. (2007a), Dennis et al. (2008), Hemrajani et al. (2008), Symonds et al. (2009)
Edwardsiella ictaluri lux Karsi et al. (2006)
Escherichia coli lux, luc Rocchetta et al. (2001), Jawhara & Mordon (2004, 2006), Demidova et al. (2005),
Lane et al. (2007), Foucault et al. (2010)
Haemophilus influenza lux Mason et al. (2005), Novotny et al. (2005), Jurcisek et al. (2007), Bookwalter et al. (2008)
Listeria monocytogenes lux Hardy et al. (2004, 2006, 2009), Riedel et al. (2007b, 2009), Disson et al. (2008, 2009)
Mycobacterium bovis BCG lux Heuts et al. (2009)
Mycobacterium smegmatis lux, luc Andreu et al. (2010)
Mycobacterium tuberculosis lux, luc Andreu et al. (2010)
Proteus mirabilis lux Kadurugamuwa et al. (2005b), Burkatovskaya et al. (2006)
Pseudomonas aeruginosa lux BitMansour et al. (2002), Hamblin et al. (2003), Kadurugamuwa et al. (2003a, b),
Demidova et al. (2005), Burkatovskaya et al. (2006), Riedel et al. (2007a), Ramphal et al. (2008)
Pseudomonas fluorescens lux Sedgley et al. (2004, 2005)
Salmonella enterica Typhimurium lux Contag et al. (1995), Monack et al. (2004), Burns-Guydish et al. (2005, 2007), Riedel et al. (2007a)
Salmonella enteritidis lux Brovko et al. (2003)
Staphylococcus aureus lux Francis et al. (2000), Kuklin et al. (2003), Kadurugamuwa et al. (2003a, b, 2004),
Gad et al. (2004), Wright et al. (2005), Xiong et al. (2005), Yu et al. (2005),
Burkatovskaya et al. (2006), Mortin et al. (2007), Steinhuber et al. (2008), Engelsman et al. (2009)
Staphylococcus epidermidis lux Vuong et al. (2008)
Streptococcus pneumonia lux Francis et al. (2001), Echchannaoui et al. (2002), Malley et al. (2003), McCullers & Bartmess (2003),
Orihuela et al. (2003, 2004), Kadurugamuwa et al. (2005a, c), McCullers et al. (2007),
Karlstrom et al. (2009), Kirby et al. (2009), Mook-Kanamori et al. (2009)
Streptococcus pyogenes lux Park et al. (2003)
Fungi
Aspergillus fumigatus luc Brock et al. (2008)
Candida albicans luc Doyle et al. (2006a)
Parasites
Entomeaba histolytica luc Asgharpour et al. (2005)
Leishmania amazonensis luc Lang et al. (2005)
Leishmania major luc Lecoeur et al. (2007, 2010)
Plasmodium berghei luc Franke-Fayard et al. (2005, 2008), Amante et al. (2007), Ploemen et al. (2009), Spaccapelo et al. (2010)
Toxoplasma gondii luc Hitziger et al. (2005), Saeij et al. (2005), Lambert et al. (2006), Boyle et al. (2007),
Dellacasa-Lindberg et al. (2007), Vyas et al. (2007), Di Cristina et al. (2008)
Trypanosoma brucei ruc Claes et al. (2009), Vodnala et al. (2009)
Trypanosoma cruzi luc Hyland et al. (2008)
Viruses
Equine encephalitis virus luc Gardner et al. (2008)
Herpes simplex virus Type I luc, rluc Luker et al. (2002, 2003), Krug et al. (2004), Luker & Leib (2005), Burgos et al. (2006)
Infectious hematopoietic
necrosis virus
rluc Harmache et al. (2006)
Koi herpes virus luc Costes et al. (2009)
Murine gammaherpes virus luc Hwang et al. (2008, 2009), Jia et al. (2010)
Murine herpes virus 4 luc Gill et al. (2009), Milho et al. (2009)
Sendai virus luc Miyahira et al. (2009)
Sindbis virus luc Cook & Griffin (2003), Tseng et al. (2004)
Vaccinia virus luc Luker et al. (2005), Hung et al. (2007), Rivera et al. (2007)
Varicella zoster virus luc Zhang et al. (2007)
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levels of reporter gene expression, (2) wavelength of light
emitted (as a result of the reporter gene chosen), (3) excitation
wavelength (fluorescence), and perhaps, to some extent, (4)
the availability of cofactors. Themanner inwhich these factors
may be manipulated to improve detection limits are discussed
below. However, it is important to stress that the maintenance
and expression of high levels of recombinant DNA may place
an unwelcome metabolic burden on many microorganisms.
Indeed, a number of researchers have described attenuation in
lux- and GFP-expressing strains (Rocchetta et al., 2001;
Bumann, 2002; Hardy et al., 2004; Sanz et al., 2008).
Reporter gene expression
In addition to copy number (discussed previously), robust
levels of reporter gene expression are a function of tran-
scriptional and translational signals. As a result, the selection
of appropriate promoters is important for optimizing
reporter levels. One area of optimization that is yet to be
fully explored is that of codon usage. While this has proved
unnecessary for most organisms expressing the lux operon,
the sequence of the lux genes is AT-rich (4 69%) and as a
result they are not expressed efficiently in high-GC bacteria
such as Streptomyces coelicolor. Furthermore, in S. coelicolor
there is only one tRNA for the leucine-encoding codon
(TTA), encoded by bldA, which is developmentally regulated
in a number of Streptomyces spp. However, there are 63 TTA
codons in the native lux operon. Craney et al. (2007)
constructed an entirely synthetic lux operon lacking TTA
codons and in which the majority of codons end in a G or
C. The synthetic operon was found to be functional in
S. coelicolor and to accurately report complex developmental
gene expression patterns (Craney et al., 2007). Furthermore,
codon optimizing the firefly luciferase for M. tuberculosis
resulted in a 30-fold increase in signal (Andreu et al., 2010).
Perhaps most impressive of all, a combination of codon
optimization, removal of cryptic splice sites and retroviral
modification was used to engineer an enhanced firefly
luciferase vector that allowed the generation of highly
bioluminescent T cells, permitting the detection of as few
as three cells implanted subcutaneously into mice (Rabino-
vich et al., 2008). However, it is important to note that
codon optimization may have unforeseen effects; the lux
operon codon optimized forM. tuberculosis was found to be
nonfunctional (Andreu et al., 2010). While we have not
explored the basis for this inactivity, there is a suggestion
from the optimized sequence that after transcription, the
DNAmay form secondary structures that impede translation.
Wavelength of light emitted
For bioluminescence, it is possible that utilizing the firefly
luciferase rather than the lux operon may result in improve-
ments in the limits of detection in vivo. This would almost
certainly be due to the red-shifted emission spectra (Zhao
et al., 2005a) and increased efficiency of the firefly luciferase
(Ando et al., 2007). However, unlike the lux operon, the
generation of a bioluminescent signal is entirely dependent
on the efficient delivery of exogenous substrate.
Increasing cofactor availability
For bacteria expressing the lux operon, it is possible that the
availability of aldehyde and FMNH2 are limiting factors.
Indeed, cloning an extra promoter in front of luxCDE to
boost substrate synthesis resulted in a sixfold higher signal
in M. smegmatis (Andreu et al., 2010) and S. aureus (Mesak
et al., 2009). Furthermore, in yeast, coexpression of luxAB
together with the frp gene, encoding an NADPH–FMN
oxidoreductase from V. harveyi, led to a 100-fold increase
in luminescence (Gupta et al., 2003). Similarly, Mesak et al.
(2009) cloned the V. harveyi frp into their constructs for use
in S. aureus but were unable to obtain any transformants
with these plasmids. The authors suggested that the appar-
ent toxicity of frp to S. aureus may be due to the generation
of superoxide (O2
) as a result of the auto-oxidation of
flavoproteins.
Applications of BPI to infectious disease
research
The use of BPI for studying infectious microorganisms
in vivo represents an elegant and simple approach, avoiding
many of the problems associated with conventional meth-
ods, such as those based on obtaining viable counts. The
most widespread conventional approach involves euthaniz-
ing groups of animals at numerous time points, followed by
the preparation of suspensions of organs/tissues of interest,
which are then plated onto selective media and the number
of viable microorganisms determined. Although providing a
picture of the progression of the infection, this cumbersome
technique has many limitations. Firstly, such data provide
researchers with snapshots of the infection only at the
particular time points and in those organs/tissues analysed.
Importantly, it is impossible to discern what happened
between any two given time points, or whether the infection
progressed beyond the organs/tissues selected for analysis.
Secondly, the dynamics of the infection cannot be followed
in the same group of animals; the data at each time point is
obtained using different animals, which may lead to the
introduction of confounding errors. Thirdly, the results are
retrospective, thus preventing the ability to make ‘on-the-
spot’ decisions based on the level of infection, such as
whether to start a treatment. In contrast, BPI offers the
ability to gather real-time information on infection progres-
sion using the same group of animals. Moreover, because the
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whole animal is imaged, microorganisms can be detected at
any location including those previously unknown, provided
they are present in sufficient numbers to be detected above
background. BPI therefore maximizes the amount of infor-
mation that can be obtained from a single experiment while
drastically reducing the number of animals required. The
use of BPI can result in important new insights into the
niches exploited by pathogens during infection, challenging
conventional dogma and opening new avenues for research
into therapeutic agents and vaccines.
Noninvasive imaging of bioluminescence
in infectious disease research
BPI using bioluminescence is now well-established in the
field of infectious disease research and has utilized a number
of approaches: (1) monitoring the numbers and location of
microbial pathogens, (2) monitoring the timing and loca-
tion of microbial gene expression (e.g. those genes involved
in virulence), (3) monitoring the efficacy of antibiotic
treatment or vaccination, and (4) monitoring the host
response.
Monitoring pathogen numbers and location:
investigating the dynamics of infection in
real-time
The first reported use of BPI to track pathogenic micro-
organisms in animals was presented by Contag and collea-
gues 15 years ago using S. enterica serovar Typhimurium
transformed with the luxCDABE operon (Contag et al.,
1995). This seminal publication not only proved that
bacteria could be detected in intact living mice, but that the
technique could be used to impart important information
regarding the infection process. Indeed, the authors used
BPI to illustrate differences in the colonization pattern of
three Salmonella strains with varying degrees of virulence, as
well as the effects of inoculation route and mouse strain
used. In the intervening years, the validity of BPI in out-
lining the dynamics of growth and dissemination that
encompass infection in vivo has been proven for a number
of bioluminescently labelled microbial pathogens, including
bacteria, viruses, fungi and parasites (Table 6).
Bacterial pathogens
Bacillus anthracis is a sporulating Gram-positive bacterium
responsible for causing anthrax. Anthrax can progress in
three different forms depending on the route of infection:
cutaneous, gastrointestinal and inhalational. Using spores of
B. anthracis expressing the lux operon, Glomski et al.
(2007b) sought to investigate the patterns of growth asso-
ciated with the three different types of infection. Because
spores are metabolically inert, germination could be easily
determined by the appearance of the luminescent signal.
The researchers found that germination and initial growth
take place at the site of inoculation in both cutaneous and
inhalational infections, ruling out the previously thought
essential involvement of the draining lymph nodes. If this
holds true for human infection, this finding has important
implications for the time within which antibiotic therapy
should be administered. Furthermore, image-guided dissec-
tion allowed the authors to point to the Peyer’s patches
(aggregations of lymphoid tissue in the walls of the intes-
tines) as the primary site of bacterial growth after intragas-
tric inoculation. All routes of infection progressed to the
draining lymph nodes, spleen and eventually lungs and
blood. Luminescence correlated with bacterial counts in the
ear, superficial parotid lymph node, spleen and right lung.
However, because of differences in organ location and
pigmentation, the limits of detection ranged from
3 103 CFU for the ear to 2 105 CFU in the spleen. Like-
wise, quenching of the light emitted from the left lung by the
heart was detected. The study utilized a capsulated nontox-
inogenic strain of B. anthracis; however, for safety reasons
toxinogenic noncapsulated strains are frequently used in
combination with sensitive mouse strains. To assess the
consequences of the lack of capsule in the growth and
dissemination of B. anthracis, a luminescent lux1 toxino-
genic noncapsulated strain was used to compare the infec-
tion dynamics with that of the previously described
capsulated nontoxinogenic strain in a cutaneous model of
infection (Glomski et al., 2007a). Importantly, the research-
ers found that the noncapsulated toxinogenic bacteria were
confined to the site of inoculation for longer than the
capsulated nontoxinogenic strain. Furthermore, after pro-
gressing to the draining lymph nodes, dissemination to
other organs was also delayed and, in contrast to the
capsulated nontoxinogenic strain, colonization of the spleen
was minimal. The use of BPI has therefore allowed research-
ers to gain insights into the patterns of growth and dis-
semination of B. anthracis, describing new sites of infection
and identifying previously unknown colonization differ-
ences between strains. Importantly, these findings highlight
the need for a careful choice of infection model according to
the experimental question being addressed.
Listeria monocytogenes is another example in which the
use of BPI has uncovered novel niches during infection.
While using a lux1 L. monocytogenes strain, Hardy et al.
(2004) discovered a strong focal signal in the thoracic region
of most of the mice that had been either intravenously
or orally inoculated. Image-guided dissection allowed
the researchers to identify the gallbladder as the source
of the signal. Moreover, histological analysis showed L.
monocytogenes growing extracellularly in the lumen of the
gallbladder, a very inhospitable environment where only S.
enterica serovar Typhi was previously thought to grow. In
FEMS Microbiol Rev 35 (2011) 360–394c 2010 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
374 N. Andreu et al.
fact, the gallbladder is where Salmonella is located in
asymptomatic carriers who excrete the pathogen within the
faeces, thus providing an efficient means of transmission
(Levine et al., 1982). Similarly, the gallbladder could con-
stitute the niche by which L. monocytogenes is transmitted by
asymptomatic carriers. To address this question, Hardy et al.
(2006) monitored bioluminescent L. monocytogenes growing
in the gallbladder after inducing its contraction either by
feeding mice with milk or by injecting them with the
hormone cholecystokinin. To succeed it was very important
to ensure that the bacteria were growing in the gallbladder at
the point of inducing contraction. This would have been
quite difficult using retrospective CFU assays but was easily
achieved using BPI. Using a lux1 attenuated L. monocyto-
genes strain, which could be administered as a larger dose,
the researchers reported seeing the photonic signal leaving
the gallbladder and moving along the gut until it reached the
point where faeces were being formed. The signal appeared
and disappeared as it travelled through the gut, which was
related to changes in the location of the bacteria relative to
the surface of the mice as proved by ex vivo imaging. This is a
good example of how the signal intensity depends not only
on the amount of bacteria but also on their location. Listeria
monocytogenes was also detected in the faecal pellets, in-
dicating that faeces may represent a source for reinfection or
new infections. More recently, BPI has been used to study
bone marrow infection by L. monocytogenes (Hardy et al.,
2009). As previously observed, infection of mice by this
bacterium was cleared during the first hours, followed by
dynamic relapses in different locations, including the bones.
This complex pattern of infection would have been very
difficult to identify using conventional methods because of
the variety of sites of infection, the fluctuations in the levels
of bacteria over time and inter-mouse variation. Lumines-
cent signals in the bones were mainly located in the tibia and
phalanges of the hind legs and lasted for several days
particularly in the case of attenuated lux1 L. monocytogenes
strains. Image-guided dissection and histology showed that
bacteria replicated in the bone marrow without causing any
observable pathology. Importantly, the presence of bacteria
in the bones was without any evident clinical symptoms,
thus emphasizing the crucial role of BPI in the detection of
this infection.
Brucellosis, caused by Brucella melitensis, is a disease that
can progress as an acute or chronic infection affecting a
broad range of tissues; hence it represents another case in
which the use of BPI has the potential to make important
contributions to our understanding of the infection. Raja-
shekara et al. (2005) analysed an acute infection model in
susceptible and resistant mice using a lux1 strain. A similar
pattern of dissemination was revealed in both mouse strains
with signals detected at the site of inoculation (peritoneum),
in the inguinal lymph nodes, liver, and spleen, and in two
newly described locations of relevance for human infection:
the testes and submandibular regions. In addition, a chronic
infection model was developed in resistant mice and in
susceptible mice infected with a low dose, which was
characterized by waves of growth and clearance of B.
melitensis in the submandibular region and tail. The in vivo
imaging results correlated well with ex vivo imaging and
CFU counts for all the organs tested.
Meningococcal sepsis is another infectious disease whose
research has also benefitted from the application of BPI.
Sjolinder & Jonsson (2007) used a lux1 Neisseria meningiti-
dis strain to infect CD46 transgenic mice, which are suscep-
tible to meningococcal disease in contrast to resistant wild-
type mice. The infection resulted in three distinct disease
patterns: sepsis, meningitis and mild disease. Sepsis and
meningitis were found to result in death within 3 days,
whereas mild disease was characterized by clearance fol-
lowed by relapses with bacteria either localized in the central
nervous system or the circulation resulting in bacteraemia.
Additionally, strong photonic signals were detected in the
thyroid gland and nasal region. Further analysis of the
thyroid gland indicated that colonization was related to
lower levels of the thyroid hormone in the transgenic mice,
which would point at an impaired thyroid function as a risk
factor for meningococcal disease. CFU and immunohisto-
chemical analysis of the nasopharynx gave the first evidence
N. meningitidis translocates from blood to the respiratory
mucosa. Moreover, using a bioluminescent N. meningitidis
strain deficient in the pilus-associated adhesin PilC1, the
researchers found that this protein plays a crucial role in this
process.
Another area of research in which use of BPI represents an
important improvement is in the study of biofilm formation
in vivo. Conventional methods require removing the device
that acts as support for the biofilm followed by detaching
and quantification of the bacteria, and therefore do not
allow longitudinal monitoring of the infection. The useful-
ness of BPI in this field was first demonstrated by Kadur-
ugamuwa et al. (2003a) using implanted catheters colonized
by either lux1 S. aureus or lux1 P. aeruginosa. In both cases,
bioluminescence correlated to CFU numbers throughout
the experiment. More recently, BPI was used to monitor S.
aureus in a soft tissue implant infection model (Engelsman
et al., 2009). In contrast to other biofilm studies, in this
model growth of the bacteria was not restricted to the
device; instead, an infected mesh was subcutaneously im-
planted, thus allowing the bacteria to spread into the
surrounding tissues. Bioluminescence over the mesh area
correlated with ex vivo bacteria enumeration by confocal
microscopy.
Recently the dynamics of faecal–oral transmission was
studied using a lux1 derivative of C. rodentium, a natural
murine pathogen (Wiles et al., 2005a). In this model, a
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single mouse, infected by oral gavage with bacteria grown in
culture, is reintroduced into a cage containing its littermates
and allowed to infect them. BPI was used to study the tissue
distribution of bacteria in animals infected by the two routes
and revealed startling differences. In particular, bacteria
grown in culture were found to require a large infecting
dose and initially small numbers colonize the caecum for a
period of several days before going on to infect the lower
reaches of the colon (Wiles et al., 2004, 2006b). By contrast,
C. rodentium shed in infected murine stool was shown to
have an approximately 1000-fold lower infectious dose,
indicating that after adaptation to the murine host C.
rodentium becomes relatively hyperinfectious when subse-
quently shed into the environment (Wiles et al., 2005a), and
remain in this state for several days (Bishop et al., 2007).
Furthermore, host-passaged bacteria were found to imme-
diately colonize the colon, suggesting that strains grown in
culture require a period in which to adapt to the new
environment. The classic definition of refinement described
earlier can be extended beyond minimizing pain and suffer-
ing to ensuring the model used is the best representation of
the disease under study. In the case of C. rodentium, a model
for human gastrointestinal pathogenic E. coli, the insights
provided by BPI in comparing infections initiated by oral
gavage and natural transmission resulted in the develop-
ment of an animal model that more realistically models the
human infection, while requiring far fewer animals to
undergo the invasive oral gavage procedure.
Fungal pathogens
To date, the infection dynamics of two fungal species have
been investigated using BPI, Aspergillus fumigatus and
Candida albicans. Aspergillus fumigatus causes life-threaten-
ing aspergillosis in immunocompromised patients while C.
albicans is an opportunistic pathogen that commonly re-
sides in the human digestive system and vaginal tract as a
commensal yeast. Brock et al. (2008) developed biolumines-
cent A. fumigatus using a derivative of the firefly luciferase
gene, codon optimized for use in mammalian cells, and
found that differences in the light emission of the transfor-
mants was related to the number of copies of luciferase
introduced. The bright transformant C3, found to have four
luciferase copies, was selected for further study. Using a
model of invasive pulmonary aspergillosis in which corti-
costeroid-treated mice are intranasally inoculated with high
numbers of conidia, the researchers determined that A.
fumigatus C3 was not attenuated, leading to respiratory
failure 3–4 days after infection. Interestingly, light emission
was found not to be a good indicator of fungal load in this
model; the photonic signal from the lungs peaked 1 day
postinfection and then decreased while the clinical symp-
toms of infection continued indicating a progression of
infection. Furthermore, high fungal densities were evident
by histology. The authors suggested that the disparity
between light emission and fungal load may be due to
inefficiencies in luciferin distribution as a result of the severe
clinical symptoms exhibited, as well as the presence of
pulmonary lesions that may have been severe enough to
restrict oxygen dispersion in the bronchoalveolar tree. In-
deed, the researchers found a strong increase in light emis-
sionwhen luciferin was directly administered to lungs ex vivo.
Doyle et al. (2006b) developed bioluminescent C. albicans
using a codon optimized derivative of the firefly luciferase
gene. The researchers found that while luciferase activity in
protein extracts taken from C. albicans growing as yeast or
hyphae were almost identical, light output from the hyphal
stage was massively reduced (Doyle et al., 2006a). This was
attributed to a reduced ability of luciferin to cross the hyphal
cell wall and was a disappointing finding as in C. albicans
hyphal growth is associated with the fungus in its patho-
genic, infectious form. Indeed, Doyle and colleagues found
that the bioluminescent signal was generally too low to
monitor chronic systemic infection in vivo using BPI. In
contrast, BPI was successful in monitoring C. albicans
infection in a vulvo-vaginal model as this infection is
characterized by the presence of both the hyphal and yeast
morphologies, with the sloughing off of the latter cell type.
Parasites
Trypanosoma spp. are eukaryotic parasites endemic in
Africa, Latin America and Asia. Trypanosoma cruzi is the
causative agent of Chagas disease; acute disease is typically
characterized by high parasitism, fever and lymphadeno-
pathy, which commonly progresses to a chronic phase
where cardiac alterations or gastrointestinal disorders are
observed. Hyland et al. (2008) developed firefly luciferase-
expressing T. cruzi and were able to follow parasite dissemi-
nation over the course of a 25-day infection using BPI.
Trypanosoma brucei subspecies brucei is transmitted by the
tsetse fly and causes human African trypanosomiasis, also
known as sleeping sickness. Claes et al. (2009) generated T.b.
brucei stably expressing the Renilla luciferase and character-
ized parasite infection dynamics in intraperitoneally in-
fected mice. Interestingly, the authors found an abundance
of parasites in the testes of infected male mice, but no
apparent tropism for the sexual organs of female mice.
Furthermore, T.b. brucei could be observed extravascularly
in the testes but not in the seminiferous duct, suggesting
sexual transmission was unlikely. Indeed, no female mice
became infected when mated with T.b. brucei-infected males.
Furthermore, no offspring were generated, suggesting that
the presence of parasites in the testes leads to male sterility.
It would be interesting to determine whether the tropism of
T.b. brucei for the testis holds true in models that more
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realistically mimic the natural route of parasite transmis-
sion, for example subcutaneous injection to mimic delivery
from the tsetse fly. Importantly, the researchers noted that
administration of the coelenterazine substrate required for
generation of a photonic signal resulted in nonhomogenous
distribution with different patterns of light emission ob-
served after intraperitoneal and intravenous delivery.
Leishmania spp. are intracellular protozoan parasites
transmitted from the sandfly during a blood meal to a
variety of mammalian hosts. These dimorphic parasites exist
as extracellular flagellated promastigotes in the insect vector
and as obligate intracellular amastigotes in the mammalian
host. Lang et al. (2005) generated Leishmania amazonensis
recombinants stably expressing the firefly luciferase gene
and visualized the presence of metacyclic promastigotes into
the ear dermis of mice using BPI. Bioluminescent signals,
measured at the inoculation site and in the draining lymph
node, correlated well with classical methods for quantifica-
tion of parasites and allowed the monitoring of parasite
loads before any clinical signs of leishmaniasis were detect-
able. Similarly, Lecoeur et al. (2007) developed firefly
luciferase-expressing Leishmania major and determined the
limits of detection to be approximately 5000 parasites within
the murine ear.
Toxoplasma gondii is an obligate intracellular parasite that
can cause severe disease in individuals with immature or
suppressed immune systems. The parasite has two forms
that express distinct surface antigens; the rapidly dividing or
tachyzoite form is associated with acute infection, while the
bradyzoite form is associated with asymptomatic chronic
infection. A number of researchers have reported the devel-
opment of firefly-expressing derivatives of different T. gondii
strains (Hitziger et al., 2005; Saeij et al., 2005; Lambert et al.,
2006; Vyas et al., 2007; Di Cristina et al., 2008). Interestingly,
Saeij et al. (2005) reported that all mice infected with T.
gondii strain S23-luc7 that died in the acute phase of
infection developed a signal around the ventral side of the
neck, which was identified as originating from the cervical
lymph nodes and is similar to the situation in humans.
However, dissection of animals also showed a clear signal
emanating from specific regions of the brain, which was not
observed when the animals were imaged while anaesthes-
tized. In contrast, Hitziger et al. (2005) were able to visualize
the dissemination of T. gondii strain RH to the brain, eyes
and testes in addition to the spleen and liver. Such differ-
ences could be due to strain differences as well as imaging
parameters; importantly, visualizing the signal emanating
from the eyes and brain required the bodies of the animals to
be covered with black card to block the stronger photon
emission of T. gondii in other niches.
Firefly luciferase-expressing malaria parasites have been
used in a number of studies to monitor the interactions
between Plasmodium berghei and its murine host. Initial
studies concentrated on investigating the blood-borne stages
of infection. For example, Plasmodium-infected red blood
cells are known to adhere to the endothelial cells of the
microvasculature of numerous deep tissues. This process,
known as sequestration, has long been considered to lead to
the pathology of cerebral malaria. However, using BPI,
Franke-Fayard et al. (2005) determined that sequestration
was not the basis for murine cerebral malaria and revealed
an unexpected tissue (adipose) in which sequestration
occurs. These studies relied on establishing malaria in mice
by administering Plasmodium-infected red blood cells by the
intraperitoneal route. Importantly, the liver is the main site
for intracellular development of Plasmodium sporozoites in
humans and rodents upon being bitten by an infected
mosquito. Ploemen et al. (2009) utilized firefly luciferase-
expressing P. berghei to study this important phase of the
parasites life cycle. Parasites were administered to mice
either by intravenous injection of sporozoites or by mosqui-
to bite, and the liver stage of Plasmodium was visualized by
BPI. In this manner, the authors were able to discriminate
less than five infected hepatocytes per liver using planar
luminescence imaging. Furthermore, this study was one of
the few reports in the literature of bioluminescence tomo-
graphic imaging utilizing the now discontinued IVIS 3D
system, which allowed the discrimination of individual
infected hepatocyctes.
Viral pathogens
The first report of BPI to monitor viral pathogens was by
Luker et al. (2002), who utilized a dual firefly and Renilla
luciferase-expressing derivative of herpes simplex virus type
1 (HSV-1). While viral infection in mouse footpads, perito-
neal cavity, brain, and eyes could be detected after adminis-
tration of luciferin, the activity of Renilla luciferase could
only be visualized after direct administration of coelenter-
azine to infected eyes and not following the systemic delivery
of substrate. Importantly, the photonic signal derived from
the expression of firefly luciferase in vivo correlated directly
with input titers of recombinant virus used for infection.
One minor drawback of utilizing BPI to study microbial
pathogenesis is that the technique requires bioluminescent
derivatives of different strains to be developed. This may
result in unforeseen effects on virulence, in addition to the
time and resources required. Luker & Luker (2010) devel-
oped a novel alternative approach to this strategy with the
construction of a transgenic mouse that expresses firefly
luciferase only in response to HSV-1 infection (Luker et al.,
2006). After infection with three different strains of HSV-1,
luciferase expression in the transgenic mice reproduced the
established spatial and temporal progression of infection,
with the photonic signal reflecting the input viral titers.
However the authors noted that the lower limits of detection
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were approximately 10-fold higher than when using lucifer-
ase-expressing HSV-1. Importantly, this decrease in sensi-
tivity resulted in a delay of 1–2 days before viral infection
could be detected. Furthermore, relatively high basal levels
of luciferase expression were observed in the paws, ears and
tail, limiting the usefulness of the reporter mouse strategy
for studies utilizing the footpad inoculation route.
Sindbis virus (SV) is an alphavirus that causes encepha-
litis and paralysis in mice and therefore serves as an excellent
model for studying acute viral encephalitis. For alphaviruses
(and others found in plasma), viral spread from the periph-
ery to the central nervous system has been difficult to study
due to the confounding effects of free virus in the blood.
Indeed, determination of replication in specific tissues
requires the identification of infected cells by methods such
as immunohistochemistry. As firefly luciferase requires ATP
to generate light, Cook & Griffin (2003) developed firefly
luciferase-expressing variants of SV and utilized BPI to
visualize only virus actively replicating within cells. Mice
were subcutaneously inoculated in the right rear foot and
viral replication in the brain was always found to be
preceded by replication in either the nose or lower spinal
cord. This suggests that virus entry into the nervous system
can occur by retrograde axonal transport either from
neurons innervating the initial site of replication or from
the olfactory epithelium after viraemic spread. BPI was also
utilized to examine the reactivation of gammaherpesviruses,
which can establish life-long persistency inside host cells.
Using a firefly luciferase-expressing derivative of murine
gammaherpesvirus 68 (MHV-68), Hwang et al. (2008)
visualized the spontaneous reactivation of MHV-68 from
latency, as well as following treatment with either a protea-
some inhibitor or an immunosuppressant agent. Further-
more, BPI revealed viral replication in the salivary glands, an
important finding that suggests that MHV-68 may also be
transmitted through saliva, similar to a number of human
herpesviruses.
Host range of BPI
The majority of reports of BPI to date involve using mice as
the host species. The reasons for this are twofold: (1) mice
account for a majority of the animals used in scientific
procedures (Trull & Rich, 1999; UKHO, 2009), and (2) their
small size minimizes attenuation of the photonic signal
caused by the distance the signal must travel to reach the
surface. However, the technique is not limited to mice and
has been applied to other species, most notably to study
gene transfer efficiency in infant monkeys (the long-tailed
macaque, Macaca fascicularis) (Tarantal et al., 2006). In
infectious disease research, BPI has been applied to a
chinchilla model of Haemophilus influenza otitis media,
allowing the noninvasive monitoring of the infection within
the pharynx, eustachian tube, and middle ear after intrana-
sal and transbullar inoculation (Novotny et al., 2005). The
limit of detection for BPI in the nasopharynx was found to
be 105 CFUmL1 of nasopharyngeal lavage, less than the
conventional CFU method. In contrast, detection of lumi-
nescence within the middle ear cavity appeared to be more
sensitive than culture, which could be related to the presence
of a subpopulation of adherent cells that would be recovered
by lavage less efficiently. Likewise, BPI was used to detect
fetoplacental transmission of L. monocytogenes in a gerbil
infection model (Disson et al., 2008), and to monitor
spatiotemporal progression of bacterial peritonitis in rats
(Sharma et al., 2010).
In addition to rodents, BPI has also been applied to the
study of infection in fish. A lux1 Edwardsiella ictaluri strain
was used to study bacterial dissemination in channel catfish
(Karsi et al., 2006). Intraperitoneal inoculation was used to
determine the limit of detection in vivo, which was found to
be approximately 104 CFU in non-albino fish. In addition,
fish immersed in water containing the luminescent bacteria
allowed the visualization of bacterial attachment to specific
novel sites on the fish’s surface. This was followed by spread
of the bacteria to various areas and eventual dissemination
through the whole body. Moreover, ex vivo analysis corro-
borated previously known target organs of infection (the
kidneys, spleen and gills) while identifying new ones (e.g.
the heart). Interestingly, the authors found that E. ictaluri
infection was characterized by an initial period of stable
bacterial numbers followed by a period of rapid bacterial
replication and dissemination, suggesting that the organism
must first reach a certain population density before causing
disease. Once the bioluminescent signal reached approxi-
mately 108–109 photons s1 cm2 steridian (sr)1, death of
the host was imminent. In addition, Harmache et al. (2006)
utilized BPI to investigate the spread of a novirhabdovirus,
infectious hematopoietic necrosis virus (IHNV), in live
rainbow trout. Expression of the Renilla luciferase in IHNV
was found to have no effect on virulence and enabled viral
dissemination to be visualized in numerous tissues includ-
ing the oral cavity, esophagus/cardiac stomach region,
kidney and spleen after addition of substrate into the water
tank. Interestingly, the fin bases were found to be the portal
of entry in fish exposed to IHNV by bath immersion.
Similarly, Costes et al. (2009) determined the skin, and not
the gills, to be the major portal of entry for Koi herpesvirus
in carp using BPI.
Studying virulence factors and gene expression
in vivo
BPI can be used to gain insights into the in vivo role of
microbial gene products, by comparing the infection dy-
namics of wild-type and mutant tagged strains. Moreover,
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the spatiotemporal expression of a particular gene of interest
can be monitored by expressing reporter genes under
control of the promoter of a given gene, provided expression
is strong enough to generate a detectable signal. Rajashekara
et al. (2005) first applied BPI to the study of virulence factors
while screening a transposon library for a highly biolumi-
nescent strain of B. melitensis. In addition to attenuation,
revealed by reduced lethality, BPI allowed the researchers to
easily identify differences in bacterial growth and dissemina-
tion between some of the mutant strains. More recently this
approach has been used to study the role of a TIR domain-
containing protein (TcpB) of B. melitensis during infection
in mice (Radhakrishnan et al., 2009). In vitro, the authors
demonstrated that this protein plays a similar role to that of
the Toll-like receptor adaptor protein TIRAP. Furthermore,
using BPI, TcpB was found to be required for the initial
growth and spread of B. melitensis in vivo. Similarly, this
technique has been used to characterize the dissemination
patterns of various B. anthracis mutant strains deficient in
one or more toxin components (Loving et al., 2009). In this
manner, it has been found that while toxins are not required
for germination or initial replication in vivo, the lethal toxin
and, to a lesser extent, the oedema toxin are required for
dissemination beyond the draining lymph nodes. In a
similar work, BPI was used to monitor six Streptococcus
pneumoniae mutant strains lacking previously recognized
virulence factors (Orihuela et al., 2004). Different inocula-
tion routes were used to distinguish between defects in
dissemination and inability to grow in certain tissues and,
thereby to allocate the contribution of each virulence factor
to disease progression. In yet another excellent example, BPI
was used to study the involvement of the bacterial invasion
proteins InlA and InlB in maternofetal transmission of L.
monocytogenes (Disson et al., 2008). A gerbil model was used
because of the presence in this animal of functional recep-
tors for both invasiveness proteins. Fetoplacental infection
could be readily visualized using a bioluminescent wild-type
strain either after oral or intravenous inoculation, whereas
no signal in the foetus was detected when using a double-
mutant strain under the same conditions. These results were
correlated to foetal lethality and helped to prove the
involvement of InlA and InlB in fetoplacental listeriosis
in vivo.
Varicella-zoster virus (VZV) is a human alphaherpesvirus
that causes varicella (chickenpox). VZV establishes lifelong
latency in the host, with reactivation resulting in herpes
zoster (shingles). VZV possesses a DNA genome of 125 kb
that bears 70 unique ORFs; o 20% of the VZV genome has
been functionally characterized. VZV infection is restricted
to human cells, and mouse models for VZV studies are
limited to those that engraft human tissues in immunodefi-
cient mice. Zhang et al. (2007) developed a firefly luciferase-
expressing VZV derivative in which bioluminescence
correlated with viral titers both in vitro and in infected
thymus–liver implants in SCID-hu mice. Visualization of
the kinetics of VZVLuc spread in mice using BPI demon-
strated a general trend of initial exponential growth followed
by a plateau once the viral infection within the limited
implants had reached saturation. Furthermore, mutant
viruses in which ORF1 and ORF2 were deleted demon-
strated no discernible growth defect in thymus–liver im-
plants, while virus lacking ORF3 grew slightly, but not
significantly, slower than the wild-type virus. In contrast,
the implants inoculated with virus lacking ORF0 produced
photonic signals that were approximately 100-fold less than
those of VZVLuc. These data suggest that VZVORF1, ORF2
and ORF3 are dispensable, while ORF0 is required for
optimal viral growth. Similarly, Gill et al. (2009) utilized a
firefly luciferase-expressing variant of the murine gamma-
herpesvirus Murid herpesvirus-4 (MuHV-4) to investigate
the relationship between viral thymidine kinase (TK), a gene
classically essential for lytic replication in terminally differ-
entiated cells, and host entry route. The authors found that
while MuHV-4 lacking TK delivered to the lung or perito-
neum were attenuated they were able to disseminate to
lymphoid tissue. In contrast, MuHV-4 lacking TK delivered
to the upper respiratory tract resulted in no detectable
infection, suggesting TK, and by implication lytic replica-
tion, is required for MuHV-4 to establish a significant
infection by a noninvasive route.
In spite of the extensive use of luciferases as reporters to
study microbial gene expression in vitro, to our knowledge,
carrying out such studies noninvasively in animals was not
reported until 2005 with the publication of expression of the
sap operon in a chinchilla model ofH. influenza otitis media
(Mason et al., 2005). This operon has been implicated in
resistance to antimicrobial peptides (Harris et al., 2004),
some of which are known to be important in innate
immunity of the upper airway mucosa. Expression of sapA
had been previously shown to be increased in H. influenzae
recovered from the middle ear in the chinchilla model
(Mason et al., 2003). By fusing the sap promoter to the lux
operon, transient expression could be detected in the middle
ear, the eustachian tube and the pharynx. Bioluminescence
was measured in vivo and CFUs were calculated in ear fluids
and nasal lavages to work out the amount of biolumines-
cence per bacterial cell and therefore estimate variations in
expression during infection.
Almost simultaneously, Wright et al. (2005) used BPI to
study the expression and regulation of the agr system of S.
aureus in a murine subcutaneous abscess model. The agr
system, which stands for accessory gene regulator, is a
quorum-sensing system that controls the expression of S.
aureus virulence genes in response to autoinducing peptides
(AIP). There are different agr specificity groups that produce
specific AIP that competitively inhibit heterologous agr
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activation and therefore virulence. To better understand this
process, Wright and colleagues constructed two biolumines-
cent S. aureus strains in which the lux operon was under the
control of either an agr promoter or the b-lactamase
promoter (for constitutive expression). They proved that
both bioluminescence and abscess formation in the agr
reporter strain specifically correlated with the presence of a
cognate AIP whereas it could be inhibited by either hetero-
logous AIP or a synthetic antagonist. Interestingly, an eclipse
period with background levels of luminescence was detected
between 8 and 24 h postinfection for both reporter strains,
despite high bacterial loads. This effect was reversed when
infection was carried out in mice depleted of polymorpho-
nuclear leukocytes, the main immune responders to the
infection. The authors concluded that the reduction in
bioluminescence observed was likely due to a metabolic
shutdown in the bacteria, possibly after phagocytosis by the
immune cells. This highlights the importance of concur-
rently using a constitutive promoter as a control.
Steinhuber et al. (2008) reported no such problems in
their studies of the expression of the S. aureus pore-forming
alphatoxin Hla in implanted tissue cages. In this model,
bioluminescence detected in mice infected with the consti-
tutive reporter strains correlated with bacterial numbers
throughout the length of the experiment. Conversely, ex-
pression of hla was not detected until 2 days postinfection,
after which time it steadily increased until the end of the
study. Moreover, the luminescent signal was higher when lux
was expressed under control of the hla promoter in a strain
deficient in SigB, known to repress hla, whereas no signal
was detected in a strain lacking Sae, an activator of hla.
Significantly, high bacterial densities were required to gen-
erate a detectable signal illustrating the importance of
promoter strength.
Promoter strength also posed a problem for Sanz et al.
(2008) who used B. anthracis strains in which the lux operon
was expressed either under the control of the sspB spore
promoter or the PA vegetative promoter to unravel the
actual site of germination of this bacterium. The two
reporters clearly enabled the researchers to differentiate
between germination and vegetative growth in vitro.
Furthermore, germination could be detected in vivo as early
as 20min after subcutaneous inoculation. However, the
limits of detection were found to be much lower in the lungs
where luminescence was not detected until 18 h postinfec-
tion even after administration of a high infectious dose. This
delay in signal detection was due to attenuation of the light
by the tissues as demonstrated by ex vivo imaging of the
lungs. Despite this limitation, BPI allowed the researchers to
determine the time and location of germination, directing
further histological analysis. However, the luminescent
strains were found to germinate at a slower rate and had a
higher LD50 (dose at which 50% of the animals die) after
subcutaneous and intranasal inoculation. Attenuation of
lux1 strains has been noted previously for other bacteria
such as E. coli (Rocchetta et al., 2001) and L. monocytogenes
(Hardy et al., 2004), and has been attributed to the
metabolic burden caused by maintenance and expression of
the recombinant DNA.
Finally, the work of Lane et al. (2007) on uropathogenic E.
coli constitutes one of the best examples of the use of BPI to
visualize infection dynamics and gene expression in vivo.
Using an E. coli strain in which the lux operon was
constitutively expressed, the researchers could track disse-
mination of the infection from the bladder to the kidneys.
Moreover, doing the same experiment, but using the flagel-
lin promoter to drive expression of lux, Lane and colleagues
could indirectly visualize flagella expression during infec-
tion, thus proving their involvement during ascending
urinary tract infection. The authors observed a trail of
bioluminescence from the bladder to the kidneys starting at
5 h postinfection, followed by increasing levels of signal in
the kidneys and, contrary to the constitutive promoter,
decreasing amounts of light in the bladder. Bioluminescence
levels correlated with motility in vitro as well as with flagellin
expression assessed by quantitative PCR both in vitro and in
the bladder in vivo, thus proving the validity of this
approach.
Monitoring antibiotic treatment and vaccine
efficacy
One of the main bottlenecks in vaccine and drug develop-
ment is in vivo testing in animal models. This is primarily
due to the fact that conventional viable count methods are
laborious, time-consuming, and involve a huge number of
animals, thus limiting its application to high-throughput
screening. It soon became apparent that BPI could easily
overcome this handicap and assessment of the usefulness of
this method for antibiotic susceptibility testing constitutes a
common theme in many of the publications in the field. In
their seminal work, Contag et al. (1995) used BPI to study
the kinetics of ciprofloxacin treatment of mice infected with
S. enterica serovar Typhimurium over the course of 5.5 h.
Thanks to the fast turnover of the luciferase enzyme, the
effect of the antibiotic could be observed as soon as 1 h post-
treatment providing real-time information of the action of
ciprofloxacin in vivo. Later on, Rocchetta et al. (2001) tested
the utility of BPI to monitor treatment in a neutropenic
mouse thigh model of E. coli infection. Although in vivo
growth of the bioluminescent strain was lower than that of
the wild-type strain, a good correlation was found between
luminescence and CFUs, except for the earlier time points,
with a dose-dependent response for the three antibiotics
tested (ceftazidine, tetracycline and ciprofloxacin). More
recently, BPI was successfully applied to compare the activity
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of daptomycin, vancomycin and linezolid in the treatment
of peritonitis caused by methicillin-resistant or methicillin-
susceptible S. aureus in real-time (Mortin et al., 2007).
In addition, BPI has been used in two separate studies to
determine ceftriaxone and daptomycin efficacy in pneumo-
coccal meningitis (Kadurugamuwa et al., 2005c; Mook-
Kanamori et al., 2009). In the first study, bioluminescence
paralleled CFUs in the cerebrospinal fluid, thus providing a
much simpler method to monitor infection and treatment.
However, in the second work, no luminescence was detected
from the majority of the infected mice, which was attributed
to the limit of detection of the imaging system.
BPI has also been used to monitor infection by Mycobac-
terium bovis BCG in an immunocompromised mouse model
and to evaluate treatment with rifampicin and isoniazid
(Heuts et al., 2009). The most notable aspect of this work is
that only luxAB, the genes for the luciferase, were used
because the whole lux operon had never been successfully
expressed in mycobacteria before. As a result, the authors
needed to administer the toxic aldehyde substrate, which
was achieved by diluting the substrate in olive oil and
ethanol, enhancing its solubility and reducing its toxicity.
This allowed Heuts and colleagues to detect infection in the
spleens of mice 4 weeks after intravenous inoculation,
followed by dissemination to the abdominal cavity. More-
over, a reduction in CFUs and bioluminescence was found 1
and 2 weeks post-antibiotic treatment. Although the re-
searchers proved that luxAB can be used to study mycobac-
terial dissemination, drug efficacy and the role of the
immune response, they failed to detect BCG in the lungs of
infected mice despite being able to detect bacteria in these
organs by colony counting and ex vivo imaging. This could
be due to a limited distribution of the substrate, which was
administered intraperitoneally, thus posing an important
limitation to the system as the lungs are of major impor-
tance in tuberculosis research. Importantly, the functional
expression of the whole lux operon in M. smegmatis and M.
tuberculosis has recently been achieved (Andreu et al., 2010),
which should prove useful for future in vivo imaging studies
of mycobacteria.
In vivo antibiotic testing is also particularly important
and challenging in biofilm infection. The validity of BPI
for this purpose was demonstrated in the pioneering work
of Kadurugamuwa et al. (2003b) who assessed the efficacy
of tobramycin, ciprofloxacin and rifampin in the treat-
ment of mice with implanted S. aureus-infected catheters.
Again, a good correlation was found between CFUs and
bioluminescence with the first two antibiotics proving
ineffective, while a dose response reduction was obtained
after rifampin treatment. Moreover, a greater and faster
reduction in bioluminescence was detected compared with
CFUs, which is probably related to the fact that protein
synthesis is affected before a bactericidal effect can be seen.
By monitoring either CFUs or bioluminescence, relapses
were detected at different times after finishing the treat-
ment and a large proportion of bacteria recovered from
the biofilms were resistant to this antibiotic. Similar
results were obtained in subsequent studies in which
relapses and resistance after rifampicin treatment were
examined in more depth in rifampicin-sensitive (Kadur-
ugamuwa et al., 2004) and rifampicin-resistant S. aureus
(Yu et al., 2005). Relapses were observed after cipro-
floxacin treatment of catheter-associated urinary tract
infections of P. aeruginosa and Proteus mirabilis (Kadur-
ugamuwa et al., 2005b). In this study, catheters were
infected both pre- and post-implantation, which resulted
in differences in the response to treatment. Moreover, this
model allowed monitoring of dissemination of the infec-
tion to the upper urinary tract.
One of the main drawbacks of using bioluminescence for
such studies is that, because bioluminescence reflects the
metabolic state of the microorganism, it is unable to
differentiate bactericidal and bacteriostatic treatments.
However, this could be inferred by monitoring the time to
recovery of a bioluminescent signal after withdrawal of the
treatment. If the treatment is bacteriostatic, then the signal
could be expected to rapidly reappear once the microorgan-
isms begin to recover. However, if the treatment is bacter-
icidal, the signal would only reappear if not all of the
microbial population were killed, and would increase in a
manner which reflected the growth of the organism.
Furthermore, Brock et al. (2008) have suggested that biolu-
minescence allows researchers to glean important informa-
tion related to a compound’s mode of action. In their
studies using luc1 A. fumigatus, while the antifungal drugs
cycloheximide and nystatin had similar effects on fungal
growth, light emission was strongly reduced after treatment
with cycloheximide compared with nystatin. In contrast to
cycloheximide, which inhibits the de novo synthesis of
proteins (and hence luciferase expression), nystatin forms
ion channels in the fungal membrane. It would appear that
while nystatin prevents the growth of the fungus, protein
synthesis remains unaffected, at least initially.
Wound infection is another model that has utilized BPI to
not only monitor infection, but also treatment (photody-
namic therapy) with various degrees of success (Hamblin
et al., 2002, 2003; Demidova et al., 2005; Jawhara &Mordon,
2006). Among these works are also two of the few published
so far using the firefly luciferase rather than the lux operon
to study bacterial infection in vivo (Jawhara & Mordon,
2004, 2006). Furthermore, BPI has also been used to assess
bandage treatment of infected wounds (Burkatovskaya et al.,
2006).
While BPI can also be used to assess vaccine efficacy,
studies are scant in the literature. However, a good example
was reported by Rajashekara et al. (2006) using B. melitensis.
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Susceptible and resistant mice independently infected with
three attenuated strains of B. melitensis carrying the lux
operon were subsequently challenged with a virulent biolu-
minescent strain. While all the vaccinated mice survived
longer than the unvaccinated ones, the dynamics of persis-
tence and dissemination of the virulent bacteria differed in
the susceptible mice depending on the strain used as vaccine.
On the contrary, growth of virulent B. melitensis was limited
to the injection site of resistant mice regardless of the
Brucella strain used for the vaccination. Therefore, BPI was
successfully used to evaluate protection conferred by differ-
ent vaccine candidates and to determine the effect of host
background on the resolution of infection. Other examples
include the use of BPI to analyse two potential Salmonella
vaccine strains in mice of different ages (Burns-Guydish
et al., 2007) or to determine how protective antigen im-
munization affects B. anthracis growth and dissemination
(Glomski et al., 2007a).
Monitoring the host response to infection
In addition to studying the pathogen, BPI can be applied to
examine the host response during infection. This can be
achieved in three ways: (1) using labelled bacteria to infect a
mouse strain with an altered immune system (e.g. a knock-
out mouse lacking a specific aspect of innate or adaptive
immunity); (2) using transgenic mice with a reporter gene
under the control of a promoter of interest (e.g. that of a
cytokine) to study its expression during infection; and (3) a
combination of the above two methods, that is, using
labelled bacteria to infect transgenic mice.
Most of the examples published to date fall in the first
group. For example, BPI was used to study age-related
susceptibility to a bioluminescent S. enterica serovar Typhi-
murium derivative (Burns-Guydish et al., 2005). Younger
mice were found to be more susceptible to infection,
characterized by earlier and greater dissemination. More
recently, a lux1 Staphylococcus epidermidis strain was used to
assess the influence of host immune status on device-related
infection (Vuong et al., 2008), with immune-compromised
mice found to be more susceptible to infection than
immune-competent ones. BPI was used as an additional
technique to study the innate immune response to
P. aeruginosa infection in the lungs (Ramphal et al., 2008).
Wild-type and TLR2,4/mice were infected with wild-type
and flagellin-deficient lux1 P. aeruginosa, and proliferation
in the lungs monitored by in vivo imaging. The researchers
found that the knockout mice were hypersusceptible to
infection with the flagellin-deficient P. aeruginosa but not
wild-type bacteria. This was linked to a failure to control
bacterial proliferation in the lungs, which together with
other experiments demonstrates the important role of
both flagellin and lipopolysaccharides (recognized by TLR2
and 4) in triggering an appropriate innate immunity.
Similarly, BPI was applied to monitor bacterial loads in
wild-type and knockout mice infected with bioluminescent
C. rodentium to study the role of MyD88 and the p50
subunit of the transcription factor nuclear factor kappa B
(NF-kB) during gastrointestinal infections (Dennis et al.,
2008; Gibson et al., 2008). Both bioluminescence and CFUs
were higher in the MyD88/mice, while p50/mice were
found to be unable to clear C. rodentium, thus highlighting
the significant functions of MyD88 and NF-kB in control-
ling the infection.
BPI was used to identify the main host receptor involved
in sequestration of the murine malaria parasite P. berghei
(Franke-Fayard et al., 2005), the highly conserved class II
scavenger receptor CD36, which is also the main receptor for
erythrocytes infected with the human malaria parasite
Plasmodium falciparum. In an alternative strategy, Amante
et al. (2007) administered anti-CD25 monoclonal antibody
to mice in order to deplete regulatory T cells and utilized
BPI to follow the dissemination of P. berghei. Interestingly,
treatment was found to protect the animals from experi-
mental cerebral malaria, with a reduction in the accumula-
tion of parasites in the vasculature and brain in comparison
with control animals. This report was the first example to
show that regulatory T cells can contribute to pathogenesis
during infectious disease by suppressing antiparasitic im-
munity.
Interferons are one of the key mediators of host innate
immunity to viral infection, inducing an antiviral state in
infected cells and regulating the adaptive immune response
to viruses. Type I interferons are secreted by most cells in
response to viral infection, while the production of type II
interferon is restricted to activated T cells, natural killer cells,
natural killer T cells and dendritic cells. Luker et al. (2003)
utilized BPI to determine the effects of type I and II
interferons on the replication and tropism of biolumines-
cent HSV-1 in mice and demonstrated differing effects of the
two interferon types in limiting systemic viral dissemina-
tion. Following footpad or ocular infection of mice lacking
type I interferon receptors, HSV-1 spread to the parenchy-
mal organs, including the lungs, liver, spleen and regional
lymph nodes, but mice survived. In contrast, deletion of
both type I and II interferon receptors produced widespread
viral dissemination to visceral organs and the nervous
system, which was invariably lethal. Furthermore, type II
receptor knockout and wild-type mice had comparable viral
replication and localization, with no systemic viral spread or
lethality. This led the authors to conclude that while isolated
deficiency of type II interferon receptors did not affect HSV-
1 pathogenesis, loss of these receptors in combination with
genetic deletion of type I receptors has a profound effect on
susceptibility to HSV-1. Subsequently, Luker et al. (2005)
demonstrated that the replication of firefly luciferase-
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expressing vaccinia virus was significantly greater in mice
lacking receptors for type I interferon compared with wild-
type mice, and that knockout mice had greater viral
dissemination to the liver and spleen.
The second approach of using transgenic reporter mice
has not yet been fully exploited in infectious diseases
research, despite the availability of a large number of these
models. For example, transgenic mice with the firefly
luciferase gene under the control of the promoter of either
iNOS (Zhang et al., 2003), NF-kB (Carlsen et al., 2002) or
IL-1b (Li et al., 2008) have been developed. In these models,
luminescence has been shown to respond to inflammatory
signals, such as exposure to lipopolysaccharide, suggesting
they should prove useful in studying the host’s response
to infection. Indeed, Hemrajani et al. (2008) utilized an
NF-kB-reporter mouse to investigate the interplay between
a secreted bacterial virulence factor NleH, and the immune
system in C. rodentium infection. The researchers found
that the reporter animals expressed high basal levels of
luciferase from a number of organs, which resulted in no
differences being detectable by live imaging of reporter
animals infected with wild-type and nleH-deficient
C. rodentium. However, when the colons of infected and
uninfected reporter animals were imaged ex vivo, the
bioluminescent signal was significantly higher in mice
infected with the wild-type C. rodentium compared with
those inoculated with the NleH mutant, and similar to the
level of signal in mice inoculated with tumour necrosis
factor-a as a positive control.
Because transgenic reporter mice utilize the firefly lucifer-
ase, it is possible to monitor infections with lux1 bacteria
within the same animal, given that the spectra for the
bacterial and firefly luciferase are different, and the firefly
luciferase produces light only when the substrate luciferin is
provided. This combined approach was intelligently applied
by Kadurugamuwa et al. (2005a) to concurrently track
infection by S. pneumoniae and the associated neuronal
damage. Progression of the infection from the site of
inoculation, the subarachnoid cistern in the brain, down
through the spinal cord could be monitored by imaging the
luminescence produced by the lux1 S. pneumoniae. The host
response, tracked as glial fibrillary acidic protein (a marker
of neuronal damage) induced expression of the firefly
luciferase, proceeded in a parallel manner. This model was
also used to evaluate the efficacy of antibiotic treatment in
eradicating infection and limiting the neuronal damage
responsible for the sequelae associated to bacterial meningi-
tis. The researchers found that although therapy successfully
eliminated the infection even when the treatment was
initiated 17 h postinfection, neuronal injury was completely
prevented only when the treatment started 11 h postinfec-
tion, thus emphasizing the importance of prompt treat-
ment.
Noninvasive imaging of fluorescence in
infectious disease research
Imaging fluorescently labelled microorganisms noninva-
sively in vivo is still in its infancy and reports in the literature
are scant (Zhao et al., 2001; Mehta et al., 2008; Kong et al.,
2009). This is largely due to the success with which micro-
organisms can be labelled with bioluminescence coupled
with a lack of fluorescent reporters with suitable emission
wavelengths. Indeed, almost all the published reports utilize
GFP, despite its unsuitable excitation and emission wave-
lengths. However, the relative explosion in the number of
red-shifted FPs developed in recent years should see this
exciting field now begin to flourish.
Mehta et al. (2008) used BPI to visualize a GFP-expressing
derivative of the parasite L. amazonensis in a mouse foot-
pad model. This infection model has the advantage of
utilizing a superficial site that is well-isolated from the rest
of the body; therefore the background fluorescence is
relatively low while light penetration is high. Classically,
parasite burden and progression of the infection is mon-
itored by measuring the thickness of the foot pad with a
calliper (Courret et al., 2003). The authors were able to
demonstrate that parasite burden could be reliably mea-
sured using BPI by correlating fluorescence intensity to
parasite numbers, and that this approach was in fact more
sensitive than the calliper method. Parasites could be
visualized 1 week after inoculation with 107 organisms while
thickness of the foot pad only increased significantly
approximately 3 weeks postinfection. Furthermore, after 3
weeks of immunotherapy with the Leish 111f1MPL-SE
vaccine the infection was reduced; significant differences
between the treated and control group were observed after
14 and 35 days when using imaging vs. calliper measure-
ment, respectively. Zhao et al. (2001, 2005b, 2007) have
visualized a GFP-expressing auxotroph of S. enteric serovar
Typhimurium in numerous different tissues. Interestingly,
their work has not involved studying the pathogenicity
mechanisms of Salmonella but has focussed on utilizing the
GFP-expressing strain as an effective therapy for cancer.
Recently, advances in the development of NIR probes
have been exploited to visualize schistosomes in vivo.
Schistosomes are intravascular, parasitic helminths that have
a high concentration of cathepsin in their gut and can
therefore activate the NIR probe ProSense680 (VisEn Med-
ical Inc., Bedford, MA) (Krautz-Peterson et al., 2009). To
label the intravascular worms, infected mice were simply
injected intravenously with the probe, leading to strong
fluorescence throughout the intestines. Five weeks after
infection, the authors could visualize as few as three worms
using FMTand reported that the main accumulation site for
Schistosoma mansoni is the upper mesenteric veins of the
abdomen. The fluorescent signal correlated strongly with
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parasite numbers and treatment with the drug praziquantel
significantly reduced the fluorescent signal when compared
with untreated controls.
Another exciting strategy utilizing NIR probes was recently
reported by Kong et al. (2010). Termed reporter enzyme
fluorescence, this elegant strategy involves combining endo-
genous microbial enzymes with custom-designed fluorogenic
substrates. Importantly, the fluorogenic substrates are linked
to a quencher molecule and hence only become fluorescent
after interacting with the target enzyme. Furthermore, use
of a natural enzyme prevents the potential for unforeseen
metabolic impacts due to the expression of heterologous
genes. Perhaps most exciting, REF has the potential to allow
the detection of microorganisms in patients as it does not rely
on the detection of genetically modified organisms. Kong and
colleagues utilized b-lactamase, a naturally occurring enzyme
expressed by numerous bacteria, but not their eukaryotic
hosts, and which confers resistance to penicillin and cepha-
losporin antibiotics (Davies, 1994). The M. tuberculosis b-
lactamase, BlaC, is located on the bacterial surface (Flores
et al., 2005) and constitutively expressed in vivo (Talaat et al.,
2004). Using REF, the researchers were able to detect
approximately 102 CFU of M. tuberculosis, P. aureuginosa
and S. aureus in vitro and as few as 104CFU ofM. tuberculosis
in the lungs of living mice (Kong et al., 2010).
Future perspectives
Dual bioluminescent/fluorescent labelling of
microorganisms
Providing the burden of expression is not too great, dual
labelling of microorganisms with fluorescent and biolumi-
nescent reporter genes takes advantage of the differential
behaviour and cofactor requirements of FPs and luciferases,
thus combining the strengths of each system. For example,
various groups have described strains marked with a lucifer-
ase in tandem with GFP (Unge et al., 1999; Qazi et al., 2001;
Tamagnini et al., 2008), which has allowed the discri-
mination between microbial counts (by fluorescence)
and metabolic activity (by bioluminescence). Furthermore,
fluorescence labeling allows samples to be analysed by
fluorescence microscopy and flow cytometry in addition to
BPI. Importantly, this means that more data can be gathered
using fewer experimental animals while also bridging the
gulf between the macroscopic and microscopic levels of
resolution, that is, individual microorganisms at one end of
the imaging spectrum and the detection of mass populations
in specific niches in the living animal at the other.
Spectral unmixing
The increasing availability of defined bandwidth filters for
capturing photonic signals, and improvements in spectral
unmixing algorithms to differentiate between signals with
different emission spectra, opens up exciting new avenues
for infectious disease research. One such avenue is the ability
to simultaneously monitor different bacterial strains within
the same animal, for example, in competition experiments
between wild-type and mutant strains of the same organism,
or to follow the dynamic inter-relationships between differ-
ent species. In order not to impose additional and/or
differing metabolic burdens on the bacteria under study,
the reporter genes would ideally be extremely similar
to allow true comparisons to be made between strains.
Branchini et al. (2007) have previously described the devel-
opment of two thermostable firefly luciferase variants
(PpyRE-TS and PpyGR-TS). The variants, which differ by
only four amino acids have readily distinguishable emission
spectra, with peaks of 612 nm for PpyRE-TS and 552 nm for
PpyGR-TS. Foucault et al. (2010) recently demonstrated for
the first time the use of these reporters and spectral unmix-
ing to simultaneously monitor two populations of E. coli in
the mouse gastrointestinal tract.
Multimodality imaging
The ability to coregister optical-imaging data with other
imaging modalities such as magnetic resonance imaging
(MRI) (Medarova et al., 2009), positron emission tomogra-
phy (PET) (Cao et al., 2006), single photon emission
computed tomography (SPECT) and X-ray computed to-
mography (CT) is an exciting development, allowing each
modality to bring its unique advantages to the fore, while
providing complementary information. Indeed, the ability
to monitor pathogen dynamics and host gene expression by
optical imaging, and the resultant changes in host physiol-
ogy and anatomy using other imaging modalities, will
considerably enhance our understanding of the complexities
of infection processes in vivo. Furthermore, the development
of multiple probes is attracting increasing attention. Brader
et al. (2008) recently reported the visualization in mice of a
bioluminescent strain of E. coli by both optical imaging and
PET (based on the expression of endogenous bacterial
thymidine kinase) while two commercial optical-X-ray CT
imaging systems are now available (Table 2).
BPI in nonanaesthetized animals
In planar imaging, the time required to capture an image is
determined by the level of photonic signal and the sensitivity
of the detection system, and is often in the region of 30 s to
5min. For this reason, mice are generally anaesthetized for
restraint purposes. However, a number of researchers have
highlighted the need for caution when using anaesthesia in
animal models. There are reports in the literature that
anaesthetic agents can influence neutrophil and monocyte
function (Welch, 1984); even a very brief exposure
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(o 1min) to isoflurane can profoundly affect proinflamma-
tory parameters in experimental endotoxaemia in rats
(Hofstetter et al., 2005), and that a number of anaesthetic
agents can inhibit the growth of some microorganisms but
not others (Molliex et al., 1998; Asehnoune et al., 2000;
Karabiyik et al., 2007). Importantly, it was noted many years
ago that the presence of relatively low levels of general
anaesthetics inhibited the light emitted by cultures of various
bioluminescent bacteria (Johnson et al., 1951). Subsequently,
it was shown that a good correlation existed between the
concentrations required to reduce light output from these
bacteria and those required to induce anaesthesia in animals
(Halsey & Smith, 1970; White & Dundas, 1970). More
recently, the activity of purified firefly luciferase has been
shown to be inhibited by a diverse range of general anaes-
thetics with a sensitivity that closely parallels anaesthetic
potencies in animals over five orders of magnitude (Franks &
Lieb, 1984). With the absolute requirement for anaesthesia to
perform the experiments, there has been no means of
investigating the extent to which anaesthesia may influence
optical-imaging studies. Indeed, researchers have been limited
to comparisons of different anaesthetic agents (Cui et al.,
2008). Our own preliminary data suggest a 10-fold increase in
signal intensity when using the inhalational anaesthetic iso-
flurane compared with an intraperitoneal injection of keta-
mine and xylazine to image bioluminescent C. rodentium in
the gastrointestinal tract of infected mice (Wiles, 2010).
However the opposite may be true for imaging biolumines-
cent pathogens in the lungs. Recently, optical-imaging systems
using electron-multiplying CCD cameras have become com-
mercially available (Table 2). In essence, this means that
photonic signals can now be captured within milliseconds,
allowing data to be acquired on nonanaesthetized animals.
This is a significant and exciting advance that will allow
researchers to investigate biological systems using optical
imaging without the influence of anaesthesia, as well as
offering the obvious important benefits to animal welfare.
Conclusions
The use of BPI is becoming widespread in infectious disease
research for several reasons: first, the novel insights the
technique can provide into microbial behaviour and the
niches exploited by microorganisms in vivo; second, the
impact of the technique on two of the guiding principles of
using animals in research, namely refinement and reduction.
Indeed, it is not unreasonable to speculate that the financial
benefits of acquiring maximal information using fewer
animals will see the use of BPI continue to grow in the
current economic climate. Furthermore, advances in hard-
ware, software and reporter development will continue to
expand the range of experimental questions that can be
addressed using BPI.
Note added in proof
In an exciting development, Close et al. (2010) have recently
reported the expression of a synthetic codon-optimized lux
operon in a mammalian HEK293 cell line in vitro and in vivo.
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